1	1	discussed	discuss	VBN	0	ROOT	0	9	_	_
1	2	a	a	DT	4	det	10	11	B-persongroup-7138	_
1	3	selected	select	VBN	4	amod	12	20	I-persongroup-7138	_
1	4	number	number	NN	1	dobj	21	27	I-persongroup-7138	_
1	5	of	of	IN	7	case	28	30	I-persongroup-7138	_
1	6	these	these	DT	7	det	31	36	I-persongroup-7138	_
1	7	populations	population	NNS	4	nmod	37	48	I-persongroup-7138	_
1	8	.	.	.	1	punct	48	49	I-persongroup-7138	_

2	1	The	the	DT	3	det	50	53	_	_
2	2	final	final	JJ	3	amod	54	59	_	_
2	3	section	section	NN	4	nsubj	60	67	_	_
2	4	presents	present	VBZ	0	ROOT	68	76	_	_
2	5	a	a	DT	8	det	77	78	_	_
2	6	preliminary	preliminary	JJ	8	amod	79	90	_	_
2	7	research	research	NN	8	compound	91	99	_	_
2	8	agenda	agenda	NN	4	dobj	100	106	_	_
2	9	of	of	IN	13	case	107	109	_	_
2	10	possible	possible	JJ	13	amod	110	118	_	_
2	11	or	or	CC	10	cc	119	121	_	_
2	12	putative	putative	JJ	10	conj	122	130	_	_
2	13	links	link	NNS	8	nmod	131	136	_	_
2	14	in	in	IN	16	case	137	139	_	_
2	15	these	these	DT	16	det	140	145	_	_
2	16	areas	area	NNS	13	nmod	146	151	_	_
2	17	.	.	.	4	punct	151	152	_	_

3	1	Infection-causing	infection-causing	JJ	2	amod	153	170	_	_
3	2	microbes	microbe	NNS	6	nsubj	171	179	_	_
3	3	and	and	CC	2	cc	180	183	_	_
3	4	the	the	DT	5	det	184	187	_	_
3	5	vaccines	vaccine	NNS	2	conj	188	196	_	_
3	6	designed	design	VBN	0	ROOT	197	205	_	_
3	7	to	to	TO	8	mark	206	208	_	_
3	8	combat	combat	VB	6	xcomp	209	215	_	_
3	9	them	they	PRP	10	nsubj	216	220	_	_
3	10	have	have	VB	8	ccomp	221	225	_	_
3	11	portions	portion	NNS	10	dobj	226	234	_	_
3	12	of	of	IN	13	case	235	237	_	_
3	13	proteins	protein	NNS	11	nmod	238	246	_	_
3	14	called	call	VBN	13	acl	247	253	_	_
3	15	antigens	antigen	NNS	14	dobj	254	262	_	_
3	16	.	.	.	6	punct	262	263	_	_

4	1	These	these	DT	2	det	264	269	_	_
4	2	antigens	antigen	NNS	3	nsubj	270	278	_	_
4	3	stimulate	stimulate	VBP	0	ROOT	279	288	_	_
4	4	a	a	DT	5	det	289	290	_	_
4	5	number	number	NN	3	dobj	291	297	_	_
4	6	of	of	IN	7	case	298	300	_	_
4	7	cells	cell	NNS	5	nmod	301	306	_	_
4	8	in	in	IN	11	case	307	309	_	_
4	9	the	the	DT	11	det	310	313	_	_
4	10	immune	immune	JJ	11	amod	314	320	_	_
4	11	system	system	NN	7	nmod	321	327	_	_
4	12	,	,	,	3	punct	327	328	_	_
4	13	including	include	VBG	14	case	329	338	_	_
4	14	macrophages	macrophage	NNS	3	nmod	339	350	_	_
4	15	,	,	,	14	punct	350	351	_	_
4	16	T	t	NN	17	compound	352	353	_	_
4	17	cells	cell	NNS	14	conj	354	359	_	_
4	18	,	,	,	14	punct	359	360	_	_
4	19	and	and	CC	14	cc	361	364	_	_
4	20	B	b	NN	21	compound	365	366	_	_
4	21	cells	cell	NNS	14	conj	367	372	_	_
4	22	.	.	.	3	punct	372	373	_	_

5	1	An	a	DT	3	det	374	376	_	_
5	2	immune	immune	JJ	3	amod	377	383	_	_
5	3	response	response	NN	4	nsubj	384	392	_	_
5	4	begins	begin	VBZ	0	ROOT	393	399	_	_
5	5	when	when	WRB	7	advmod	400	404	_	_
5	6	macrophages	macrophage	NNS	7	nsubj	405	416	_	_
5	7	ingest	ingest	VBP	4	advcl	417	423	_	_
5	8	antigens	antigen	NNS	7	dobj	424	432	_	_
5	9	such	such	JJ	11	case	433	437	_	_
5	10	as	as	IN	9	mwe	438	440	_	_
5	11	proteins	protein	NNS	8	nmod	441	449	_	_
5	12	entering	enter	VBG	11	acl	450	458	_	_
5	13	the	the	DT	14	det	459	462	_	_
5	14	body	body	NN	12	dobj	463	467	_	_
5	15	and	and	CC	4	cc	468	471	_	_
5	16	digest	digest	VB	4	conj	472	478	_	_
5	17	them	they	PRP	16	dobj	479	483	_	_
5	18	into	into	IN	20	case	484	488	_	_
5	19	antigen	antigen	NN	20	compound	489	496	_	_
5	20	fragments	fragment	NNS	16	nmod	497	506	_	_
5	21	.	.	.	4	punct	506	507	_	_

6	1	A	a	DT	2	det	508	509	_	_
6	2	molecule	molecule	NN	3	nsubj	510	518	_	_
6	3	called	call	VBN	0	ROOT	519	525	_	_
6	4	MHC	mhc	NN	3	dobj	526	529	_	_
6	5	(	(	CD	4	nummod	530	531	_	_
6	6	major	major	JJ	9	amod	531	536	_	_
6	7	histocompatibility	histocompatibility	NN	9	compound	537	555	_	_
6	8	complex	complex	NN	9	compound	556	563	_	_
6	9	)	)	NN	10	nsubj	563	564	_	_
6	10	carries	carry	VBZ	4	acl:relcl	565	572	_	_
6	11	certain	certain	JJ	10	dobj	573	580	_	_
6	12	of	of	IN	14	case	581	583	_	_
6	13	these	these	DT	14	det	584	589	_	_
6	14	fragments	fragment	NNS	11	nmod	590	599	_	_
6	15	to	to	TO	17	case	600	602	_	_
6	16	the	the	DT	17	det	603	606	_	_
6	17	surface	surface	NN	3	nmod	607	614	_	_
6	18	of	of	IN	20	case	615	617	_	_
6	19	the	the	DT	20	det	618	621	_	_
6	20	cell	cell	NN	17	nmod	622	626	_	_
6	21	,	,	,	3	punct	626	627	_	_
6	22	where	where	WRB	25	advmod	628	633	_	_
6	23	they	they	PRP	25	nsubjpass	634	638	_	_
6	24	are	be	VBP	25	auxpass	639	642	_	_
6	25	displayed	display	VBN	3	advcl	643	652	_	_
6	26	but	but	CC	3	cc	653	656	_	_
6	27	they	they	PRP	30	nsubjpass	657	661	_	_
6	28	are	be	VBP	30	auxpass	662	665	_	_
6	29	still	still	RB	30	advmod	666	671	_	_
6	30	locked	lock	VBN	3	conj	672	678	_	_
6	31	into	into	IN	33	case	679	683	_	_
6	32	the	the	DT	33	det	684	687	_	_
6	33	cleft	cleft	NN	30	nmod	688	693	_	_
6	34	of	of	IN	37	case	694	696	_	_
6	35	the	the	DT	37	det	697	700	_	_
6	36	MHC	mhc	NN	37	compound	701	704	_	_
6	37	molecule	molecule	NN	33	nmod	705	713	_	_
6	38	.	.	.	3	punct	713	714	_	_

7	1	These	these	DT	2	nsubj	715	720	_	_
7	2	displayed	display	VBD	0	ROOT	721	730	_	_
7	3	antigen	antigen	NN	4	compound	731	738	_	_
7	4	fragments	fragment	NNS	6	nsubjpass	739	748	_	_
7	5	are	be	VBP	6	auxpass	749	752	_	_
7	6	recognized	recognize	VBN	2	ccomp	753	763	_	_
7	7	by	by	IN	9	case	764	766	_	_
7	8	T	t	NN	9	compound	767	768	_	_
7	9	cells	cell	NNS	6	nmod	769	774	_	_
7	10	,	,	,	9	punct	774	775	_	_
7	11	which	which	WDT	12	nsubj	776	781	_	_
7	12	stimulate	stimulate	VBP	9	acl:relcl	782	791	_	_
7	13	B	b	NN	14	compound	792	793	_	_
7	14	cells	cell	NNS	12	dobj	794	799	_	_
7	15	to	to	TO	16	mark	800	802	_	_
7	16	secrete	secrete	VB	12	xcomp	803	810	_	_
7	17	antibodies	antibody	NNS	16	dobj	811	821	_	_
7	18	to	to	TO	20	case	822	824	_	_
7	19	the	the	DT	20	det	825	828	_	_
7	20	fragments	fragment	NNS	16	nmod	829	838	_	_
7	21	as	as	RB	20	cc	839	841	_	_
7	22	well	well	RB	21	mwe	842	846	_	_
7	23	as	as	IN	21	mwe	847	849	_	_
7	24	prompt	prompt	JJ	27	amod	850	856	_	_
7	25	other	other	JJ	27	amod	857	862	_	_
7	26	immune	immune	JJ	27	amod	863	869	_	_
7	27	defenses	defens	NNS	20	conj	870	878	_	_
7	28	.	.	.	2	punct	878	879	_	_

8	1	According	accord	VBG	3	case	880	889	_	_
8	2	to	to	TO	1	mwe	890	892	_	_
8	3	Berkower	Berkower	NNP	6	nmod	893	901	B-persongroup-7245	_
8	4	,	,	,	6	punct	901	902	I-persongroup-7245	_
8	5	studies	study	NNS	6	nsubj	903	910	_	_
8	6	suggest	suggest	VBP	0	ROOT	911	918	_	_
8	7	that	that	IN	24	mark	919	923	_	_
8	8	because	because	IN	12	mark	924	931	_	_
8	9	T	t	NN	10	compound	932	933	_	_
8	10	cells	cell	NNS	12	nsubj	934	939	_	_
8	11	only	only	RB	12	advmod	940	944	_	_
8	12	recognize	recognize	VBP	24	advcl	945	954	_	_
8	13	antigen	antigen	NN	14	compound	955	962	_	_
8	14	fragments	fragment	NNS	12	dobj	963	972	_	_
8	15	from	from	IN	16	case	973	977	_	_
8	16	proteins	protein	NNS	12	nmod	978	986	_	_
8	17	predigested	predigest	VBN	16	acl	987	998	_	_
8	18	by	by	IN	19	case	999	1001	_	_
8	19	macrophages	macrophage	NNS	17	nmod	1002	1013	_	_
8	20	,	,	,	24	punct	1013	1014	_	_
8	21	they	they	PRP	24	nsubj	1015	1019	_	_
8	22	can	can	MD	24	aux	1020	1023	_	_
8	23	not	not	RB	24	neg	1023	1026	_	_
8	24	distinguish	distinguish	VB	6	ccomp	1027	1038	_	_
8	25	between	between	IN	29	case	1039	1046	_	_
8	26	a	a	DT	29	det	1047	1048	_	_
8	27	specific	specific	JJ	29	amod	1049	1057	_	_
8	28	antigen	antigen	NN	29	compound	1058	1065	_	_
8	29	fragment	fragment	NN	24	nmod	1066	1074	_	_
8	30	that	that	WDT	31	nsubj	1075	1079	_	_
8	31	comes	come	VBZ	29	acl:relcl	1080	1085	_	_
8	32	from	from	IN	35	case	1086	1090	_	_
8	33	an	a	DT	35	det	1091	1093	_	_
8	34	infecting	infect	VBG	35	amod	1094	1103	_	_
8	35	microbe	microbe	NN	31	nmod	1104	1111	_	_
8	36	and	and	CC	35	cc	1112	1115	_	_
8	37	the	the	DT	40	det	1116	1119	_	_
8	38	same	same	JJ	40	amod	1120	1124	_	_
8	39	antigen	antigen	NN	40	compound	1125	1132	_	_
8	40	fragment	fragment	NN	35	conj	1133	1141	_	_
8	41	that	that	WDT	42	nsubj	1142	1146	_	_
8	42	comes	come	VBZ	40	acl:relcl	1147	1152	_	_
8	43	from	from	IN	45	case	1153	1157	_	_
8	44	a	a	DT	45	det	1158	1159	_	_
8	45	vaccine	vaccine	NN	42	nmod	1160	1167	_	_
8	46	(	(	CD	47	nummod	1168	1169	_	_
8	47	Chisari	Chisari	NNP	45	dep	1169	1176	B-persongroup-7139	_
8	48	and	and	CC	45	cc	1177	1180	_	_
8	49	Ferrari	Ferrari	NNP	45	conj	1181	1188	B-persongroup-7140	_
8	50	,	,	,	49	punct	1188	1189	I-persongroup-7140	_
8	51	1995	1995	CD	52	nummod	1190	1194	_	_
8	52	)	)	NN	49	appos	1194	1195	_	_
8	53	.	.	.	6	punct	1195	1196	_	_

9	1	Stimulated	stimulated	NN	3	compound	1197	1207	_	_
9	2	immune	immune	JJ	3	amod	1208	1214	_	_
9	3	cells	cell	NNS	4	nsubj	1215	1220	_	_
9	4	secrete	secrete	VBP	0	ROOT	1221	1228	_	_
9	5	a	a	DT	6	det	1229	1230	_	_
9	6	variety	variety	NN	4	dobj	1231	1238	_	_
9	7	of	of	IN	9	case	1239	1241	_	_
9	8	chemical	chemical	NN	9	compound	1242	1250	_	_
9	9	substances	substance	NNS	6	nmod	1251	1261	_	_
9	10	called	call	VBN	9	acl	1262	1268	_	_
9	11	cytokines	cytokine	NNS	10	dobj	1269	1278	_	_
9	12	,	,	,	11	punct	1278	1279	_	_
9	13	which	which	WDT	14	nsubj	1280	1285	_	_
9	14	determine	determine	VBP	11	acl:relcl	1286	1295	_	_
9	15	which	which	WDT	20	dobj	1296	1301	_	_
9	16	class	class	NN	20	nsubjpass	1302	1307	_	_
9	17	of	of	IN	18	case	1308	1310	_	_
9	18	antibodies	antibody	NNS	16	nmod	1311	1321	_	_
9	19	are	be	VBP	20	auxpass	1322	1325	_	_
9	20	generated	generate	VBN	14	ccomp	1326	1335	_	_
9	21	.	.	.	4	punct	1335	1336	_	_

10	1	The	the	DT	3	det	1337	1340	_	_
10	2	cytokine	cytokine	NN	3	compound	1341	1349	_	_
10	3	interleukin	interleukin	NN	10	nsubj	1350	1361	_	_
10	4	4	4	CD	3	dep	1362	1363	_	_
10	5	,	,	,	3	punct	1363	1364	_	_
10	6	for	for	IN	7	case	1365	1368	_	_
10	7	example	example	NN	3	nmod	1369	1376	_	_
10	8	,	,	,	3	punct	1376	1377	_	_
10	9	can	can	MD	10	aux	1378	1381	_	_
10	10	prompt	prompt	VB	0	ROOT	1382	1388	_	_
10	11	B	b	NN	12	compound	1389	1390	_	_
10	12	cells	cell	NNS	10	dobj	1391	1396	_	_
10	13	to	to	TO	14	mark	1397	1399	_	_
10	14	secrete	secrete	VB	10	xcomp	1400	1407	_	_
10	15	immunoglobin	immunoglobin	NN	16	compound	1408	1420	_	_
10	16	E	e	NN	14	dobj	1421	1422	_	_
10	17	(	(	CD	20	nummod	1423	1424	_	_
10	18	IgE	ige	NN	20	compound	1424	1427	_	_
10	19	)	)	NN	20	compound	1427	1428	_	_
10	20	antibodies	antibody	NNS	14	nmod:tmod	1429	1439	_	_
10	21	,	,	,	20	punct	1439	1440	_	_
10	22	which	which	WDT	23	nsubj	1441	1446	_	_
10	23	trigger	trigger	VBP	20	acl:relcl	1447	1454	_	_
10	24	allergic	allergic	JJ	25	amod	1455	1463	_	_
10	25	reactions	reaction	NNS	23	dobj	1464	1473	_	_
10	26	.	.	.	10	punct	1473	1474	_	_

11	1	Other	other	JJ	2	amod	1475	1480	_	_
11	2	cytokines	cytokine	NNS	3	nsubj	1481	1490	_	_
11	3	cause	cause	VBP	0	ROOT	1491	1496	_	_
11	4	B	b	NN	5	compound	1497	1498	_	_
11	5	cells	cell	NNS	3	dobj	1499	1504	_	_
11	6	to	to	TO	8	mark	1505	1507	_	_
11	7	preferentially	preferentially	RB	8	advmod	1508	1522	_	_
11	8	secrete	secrete	VB	3	xcomp	1523	1530	_	_
11	9	IgG	igg	NN	8	dobj	1531	1534	_	_
11	10	,	,	,	9	punct	1534	1535	_	_
11	11	which	which	WDT	14	nsubjpass	1536	1541	_	_
11	12	is	be	VBZ	14	auxpass	1542	1544	_	_
11	13	mainly	mainly	RB	14	advmod	1545	1551	_	_
11	14	found	find	VBN	9	acl:relcl	1552	1557	_	_
11	15	in	in	IN	17	case	1558	1560	_	_
11	16	the	the	DT	17	det	1561	1564	_	_
11	17	blood	blood	NN	14	nmod	1565	1570	_	_
11	18	,	,	,	17	punct	1570	1571	_	_
11	19	or	or	CC	17	cc	1572	1574	_	_
11	20	IgA	iga	NN	17	conj	1575	1578	_	_
11	21	,	,	,	17	punct	1578	1579	_	_
11	22	most	most	JJS	26	nsubjpass	1580	1584	_	_
11	23	of	of	IN	24	case	1585	1587	_	_
11	24	which	which	WDT	22	nmod	1588	1593	_	_
11	25	is	be	VBZ	26	auxpass	1594	1596	_	_
11	26	found	find	VBN	17	acl:relcl	1597	1602	_	_
11	27	in	in	IN	29	case	1603	1605	_	_
11	28	body	body	NN	29	compound	1606	1610	_	_
11	29	fluids	fluid	NNS	26	nmod	1611	1617	_	_
11	30	.	.	.	3	punct	1617	1618	_	_

12	1	Different	different	JJ	3	amod	1619	1628	_	_
12	2	MHC	mhc	NN	3	compound	1629	1632	_	_
12	3	molecules	molecule	NNS	4	nsubj	1633	1642	_	_
12	4	bind	bind	VBP	0	ROOT	1643	1647	_	_
12	5	to	to	TO	8	case	1648	1650	_	_
12	6	different	different	JJ	8	amod	1651	1660	_	_
12	7	antigen	antigen	NN	8	compound	1661	1668	_	_
12	8	fragments	fragment	NNS	4	nmod	1669	1678	_	_
12	9	;	;	:	4	punct	1678	1679	_	_
12	10	the	the	DT	11	det	1680	1683	_	_
12	11	set	set	NN	22	nsubj	1684	1687	_	_
12	12	of	of	IN	14	case	1688	1690	_	_
12	13	MHC	mhc	NN	14	compound	1691	1694	_	_
12	14	molecules	molecule	NNS	11	nmod	1695	1704	_	_
12	15	and	and	CC	14	cc	1705	1708	_	_
12	16	the	the	DT	17	det	1709	1712	_	_
12	17	genes	gene	NNS	14	conj	1713	1718	_	_
12	18	that	that	WDT	19	nsubj	1719	1723	_	_
12	19	commandeer	commandeer	VBP	17	acl:relcl	1724	1734	_	_
12	20	their	they	PRP$	21	nmod:poss	1735	1740	_	_
12	21	production	production	NN	19	dobj	1741	1751	_	_
12	22	vary	vary	VBP	4	parataxis	1752	1756	_	_
12	23	widely	widely	RB	22	advmod	1757	1763	_	_
12	24	from	from	IN	26	case	1764	1768	_	_
12	25	one	one	CD	26	nummod	1769	1772	B-persongroup-7141	_
12	26	individual	individual	NN	22	nmod	1773	1783	I-persongroup-7141	_
12	27	to	to	TO	28	case	1784	1786	_	_
12	28	another	another	DT	22	nmod	1787	1794	B-persongroup-7142	_
12	29	.	.	.	4	punct	1794	1795	I-persongroup-7142	_

13	1	Therefore	therefore	RB	24	advmod	1796	1805	_	_
13	2	,	,	,	24	punct	1805	1806	_	_
13	3	although	although	IN	11	mark	1807	1815	_	_
13	4	the	the	DT	6	det	1816	1819	_	_
13	5	immune	immune	JJ	6	amod	1820	1826	_	_
13	6	systems	system	NNS	11	nsubj	1827	1834	_	_
13	7	of	of	IN	9	case	1835	1837	_	_
13	8	two	two	CD	9	nummod	1838	1841	B-persongroup-7143	_
13	9	people	people	NNS	6	nmod	1842	1848	I-persongroup-7143	_
13	10	may	may	MD	11	aux	1849	1852	_	_
13	11	respond	respond	VB	24	advcl	1853	1860	_	_
13	12	to	to	TO	15	case	1861	1863	_	_
13	13	the	the	DT	15	det	1864	1867	_	_
13	14	same	same	JJ	15	amod	1868	1872	_	_
13	15	protein	protein	NN	11	nmod	1873	1880	_	_
13	16	in	in	IN	18	case	1881	1883	_	_
13	17	a	a	DT	18	det	1884	1885	_	_
13	18	vaccine	vaccine	NN	15	nmod	1886	1893	_	_
13	19	,	,	,	24	punct	1893	1894	_	_
13	20	their	they	PRP$	22	nmod:poss	1895	1900	_	_
13	21	T	t	NN	22	compound	1901	1902	_	_
13	22	cells	cell	NNS	24	nsubj	1903	1908	_	_
13	23	may	may	MD	24	aux	1909	1912	_	_
13	24	respond	respond	VB	0	ROOT	1913	1920	_	_
13	25	to	to	TO	27	case	1921	1923	_	_
13	26	different	different	JJ	27	amod	1924	1933	_	_
13	27	portions	portion	NNS	24	nmod	1934	1942	_	_
13	28	of	of	IN	30	case	1943	1945	_	_
13	29	that	that	DT	30	det	1946	1950	_	_
13	30	protein	protein	NN	27	nmod	1951	1958	_	_
13	31	.	.	.	24	punct	1958	1959	_	_

14	1	This	this	DT	2	det	1960	1964	_	_
14	2	diversity	diversity	NN	3	nsubj	1965	1974	_	_
14	3	fosters	foster	VBZ	0	ROOT	1975	1982	_	_
14	4	differences	difference	NNS	3	dobj	1983	1994	_	_
14	5	in	in	IN	6	case	1995	1997	_	_
14	6	responses	response	NNS	4	nmod	1998	2007	_	_
14	7	to	to	TO	9	case	2008	2010	_	_
14	8	vaccine	vaccine	NN	9	compound	2011	2018	_	_
14	9	antigens	antigen	NNS	3	nmod	2019	2027	_	_
14	10	.	.	.	3	punct	2027	2028	_	_

15	1	There	there	EX	2	expl	2029	2034	_	_
15	2	are	be	VBP	0	ROOT	2035	2038	_	_
15	3	at	at	IN	4	case	2039	2041	_	_
15	4	least	least	JJS	5	nmod:npmod	2042	2047	_	_
15	5	nine	nine	CD	8	nummod	2048	2052	_	_
15	6	chemically	chemically	RB	7	advmod	2053	2063	_	_
15	7	distinct	distinct	JJ	8	amod	2064	2072	_	_
15	8	classes	class	NNS	2	nsubj	2073	2080	_	_
15	9	of	of	IN	10	case	2081	2083	_	_
15	10	immunoglobulins	immunoglobulin	NNS	8	nmod	2084	2099	_	_
15	11	,	,	,	2	punct	2099	2100	_	_
15	12	and	and	CC	2	cc	2101	2104	_	_
15	13	the	the	DT	14	det	2105	2108	_	_
15	14	balance	balance	NN	25	nsubj	2109	2116	_	_
15	15	of	of	IN	18	case	2117	2119	_	_
15	16	the	the	DT	18	det	2120	2123	_	_
15	17	various	various	JJ	18	amod	2124	2131	_	_
15	18	types	type	NNS	14	nmod	2132	2137	_	_
15	19	of	of	IN	20	case	2138	2140	_	_
15	20	cytokines	cytokine	NNS	18	nmod	2141	2150	_	_
15	21	that	that	WDT	22	nsubj	2151	2155	_	_
15	22	stimulate	stimulate	VBP	20	acl:relcl	2156	2165	_	_
15	23	antibody	antibody	NN	24	compound	2166	2174	_	_
15	24	secretion	secretion	NN	22	dobj	2175	2184	_	_
15	25	determines	determine	VBZ	2	conj	2185	2195	_	_
15	26	the	the	DT	28	det	2196	2199	_	_
15	27	final	final	JJ	28	amod	2200	2205	_	_
15	28	response	response	NN	25	dobj	2206	2214	_	_
15	29	to	to	TO	31	case	2215	2217	_	_
15	30	a	a	DT	31	det	2218	2219	_	_
15	31	vaccine	vaccine	NN	25	nmod	2220	2227	_	_
15	32	.	.	.	2	punct	2227	2228	_	_

16	1	Consequently	consequently	RB	6	advmod	2229	2241	_	_
16	2	,	,	,	6	punct	2241	2242	_	_
16	3	vaccine	vaccine	NN	4	compound	2243	2250	_	_
16	4	responses	response	NNS	6	nsubj	2251	2260	_	_
16	5	can	can	MD	6	aux	2261	2264	_	_
16	6	differ	differ	VB	0	ROOT	2265	2271	_	_
16	7	between	between	IN	8	case	2272	2279	_	_
16	8	individuals	individual	NNS	6	nmod	2280	2291	B-persongroup-7144	_
16	9	because	because	IN	13	mark	2292	2299	_	_
16	10	the	the	DT	12	det	2300	2303	_	_
16	11	same	same	JJ	12	amod	2304	2308	_	_
16	12	vaccine	vaccine	NN	13	nsubj	2309	2316	_	_
16	13	stimulates	stimulate	VBZ	6	advcl	2317	2327	_	_
16	14	different	different	JJ	15	amod	2328	2337	B-persongroup-7145	_
16	15	individuals	individual	NNS	13	dobj	2338	2349	I-persongroup-7145	_
16	16	to	to	TO	17	mark	2350	2352	_	_
16	17	generate	generate	VB	13	xcomp	2353	2361	_	_
16	18	different	different	JJ	19	amod	2362	2371	_	_
16	19	amounts	amount	NNS	17	dobj	2372	2379	_	_
16	20	of	of	IN	23	case	2380	2382	_	_
16	21	the	the	DT	23	det	2383	2386	_	_
16	22	various	various	JJ	23	amod	2387	2394	_	_
16	23	cytokines	cytokine	NNS	19	nmod	2395	2404	_	_
16	24	.	.	.	6	punct	2404	2405	_	_

17	1	Vaccine	vaccine	NN	2	compound	2406	2413	_	_
17	2	responses	response	NNS	6	nsubj	2414	2423	_	_
17	3	might	might	MD	6	aux	2424	2429	_	_
17	4	not	not	RB	6	neg	2430	2433	_	_
17	5	only	only	RB	6	advmod	2434	2438	_	_
17	6	differ	differ	VB	0	ROOT	2439	2445	_	_
17	7	in	in	IN	10	case	2446	2448	_	_
17	8	the	the	DT	10	det	2449	2452	_	_
17	9	short	short	JJ	10	amod	2453	2458	_	_
17	10	term	term	NN	6	nmod	2459	2463	_	_
17	11	,	,	,	6	punct	2463	2464	_	_
17	12	but	but	CC	6	cc	2465	2468	_	_
17	13	they	they	PRP	16	nsubj	2469	2473	_	_
17	14	could	could	MD	16	aux	2474	2479	_	_
17	15	also	also	RB	16	advmod	2480	2484	_	_
17	16	vary	vary	VB	6	conj	2485	2489	_	_
17	17	in	in	IN	20	case	2490	2492	_	_
17	18	the	the	DT	20	det	2493	2496	_	_
17	19	long	long	JJ	20	amod	2497	2501	_	_
17	20	term	term	NN	16	nmod	2502	2506	_	_
17	21	if	if	IN	23	mark	2507	2509	_	_
17	22	they	they	PRP	23	nsubj	2510	2514	_	_
17	23	trigger	trigger	VBP	16	advcl	2515	2522	_	_
17	24	a	a	DT	27	det	2523	2524	_	_
17	25	predominantly	predominantly	RB	27	amod	2525	2538	_	_
17	26	IgE	ige	NN	27	compound	2539	2542	_	_
17	27	response	response	NN	23	dobj	2543	2551	_	_
17	28	.	.	.	6	punct	2551	2552	_	_

18	1	This	this	DT	2	det	2553	2557	_	_
18	2	response	response	NN	4	nsubj	2558	2566	_	_
18	3	could	could	MD	4	aux	2567	2572	_	_
18	4	trigger	trigger	VB	15	dep	2573	2580	_	_
18	5	an	a	DT	7	det	2581	2583	_	_
18	6	allergic	allergic	JJ	7	amod	2584	2592	_	_
18	7	reaction	reaction	NN	4	dobj	2593	2601	_	_
18	8	to	to	TO	10	case	2602	2604	_	_
18	9	future	future	JJ	10	amod	2605	2611	_	_
18	10	immunizations	immunization	NNS	4	nmod	2612	2625	_	_
18	11	with	with	IN	14	case	2626	2630	_	_
18	12	the	the	DT	14	det	2631	2634	_	_
18	13	same	same	JJ	14	amod	2635	2639	_	_
18	14	antigens	antigen	NNS	10	nmod	2640	2648	_	_
18	15	(	(	VBP	0	ROOT	2649	2650	_	_
18	16	IOM	IOM	NNP	15	nsubj	2650	2653	B-persongroup-7246	_
18	17	,	,	,	16	punct	2653	2654	I-persongroup-7246	_
18	18	1994a	1994a	CD	19	nummod	2655	2660	_	_
18	19	)	)	NN	16	appos	2660	2661	_	_
18	20	.	.	.	15	punct	2661	2662	_	_

19	1	To	to	TO	2	mark	2663	2665	_	_
19	2	prevent	prevent	VB	30	advcl	2666	2673	_	_
19	3	the	the	DT	4	det	2674	2677	_	_
19	4	body	body	NN	7	nmod:poss	2678	2682	_	_
19	5	's	's	POS	4	case	2682	2684	_	_
19	6	immune	immune	JJ	7	amod	2685	2691	_	_
19	7	system	system	NN	2	dobj	2692	2698	_	_
19	8	from	from	IN	9	mark	2699	2703	_	_
19	9	destroying	destroy	VBG	2	advcl	2704	2714	_	_
19	10	its	its	PRP$	12	nmod:poss	2715	2718	_	_
19	11	own	own	JJ	12	amod	2719	2722	_	_
19	12	tissues	tissue	NNS	9	dobj	2723	2730	_	_
19	13	in	in	IN	16	mark	2731	2733	_	_
19	14	what	what	WP	16	nsubjpass	2734	2738	_	_
19	15	is	be	VBZ	16	auxpass	2739	2741	_	_
19	16	known	know	VBN	9	advcl	2742	2747	_	_
19	17	as	as	IN	20	case	2748	2750	_	_
19	18	an	a	DT	20	det	2751	2753	_	_
19	19	autoimmune	autoimmune	JJ	20	amod	2754	2764	_	_
19	20	response	response	NN	16	nmod	2765	2773	_	_
19	21	,	,	,	30	punct	2773	2774	_	_
19	22	immature	immature	JJ	24	amod	2775	2783	_	_
19	23	T	t	NN	24	compound	2784	2785	_	_
19	24	cells	cell	NNS	30	nsubjpass	2786	2791	_	_
19	25	that	that	WDT	26	nsubj	2792	2796	_	_
19	26	react	react	VBP	24	acl:relcl	2797	2802	_	_
19	27	against	against	IN	28	case	2803	2810	_	_
19	28	self-antigens	self-antigen	NNS	26	nmod	2811	2824	_	_
19	29	are	be	VBP	30	auxpass	2825	2828	_	_
19	30	thought	think	VBN	0	ROOT	2829	2836	_	_
19	31	to	to	TO	33	mark	2837	2839	_	_
19	32	be	be	VB	33	auxpass	2840	2842	_	_
19	33	destroyed	destroy	VBN	30	xcomp	2843	2852	_	_
19	34	in	in	IN	37	case	2853	2855	_	_
19	35	the	the	DT	37	det	2856	2859	_	_
19	36	thymus	thymus	NN	37	compound	2860	2866	_	_
19	37	gland	gland	NN	33	nmod	2867	2872	_	_
19	38	,	,	,	30	punct	2872	2873	_	_
19	39	creating	create	VBG	30	xcomp	2874	2882	_	_
19	40	what	what	WP	42	nsubjpass	2883	2887	_	_
19	41	is	be	VBZ	42	auxpass	2888	2890	_	_
19	42	known	know	VBN	39	ccomp	2891	2896	_	_
19	43	as	as	IN	45	case	2897	2899	_	_
19	44	central	central	JJ	45	amod	2900	2907	_	_
19	45	tolerance	tolerance	NN	42	nmod	2908	2917	_	_
19	46	.	.	.	30	punct	2917	2918	_	_

20	1	Peripheral	peripheral	JJ	2	amod	2919	2929	_	_
20	2	tolerance	tolerance	NN	5	nsubj	2930	2939	_	_
20	3	might	might	MD	5	aux	2940	2945	_	_
20	4	also	also	RB	5	advmod	2946	2950	_	_
20	5	occur	occur	VB	0	ROOT	2951	2956	_	_
20	6	,	,	,	5	punct	2956	2957	_	_
20	7	whereby	whereby	WRB	21	advmod	2958	2965	_	_
20	8	those	those	DT	10	det	2966	2971	_	_
20	9	T	t	NN	10	compound	2972	2973	_	_
20	10	cells	cell	NNS	21	nsubjpass	2974	2979	_	_
20	11	that	that	WDT	14	nsubj	2980	2984	_	_
20	12	could	could	MD	14	aux	2985	2990	_	_
20	13	potentially	potentially	RB	14	advmod	2991	3002	_	_
20	14	react	react	VB	10	acl:relcl	3003	3008	_	_
20	15	to	to	TO	16	case	3009	3011	_	_
20	16	self-antigens	self-antigen	NNS	14	nmod	3012	3025	_	_
20	17	and	and	CC	16	cc	3026	3029	_	_
20	18	that	that	DT	16	conj	3030	3034	_	_
20	19	are	be	VBP	21	auxpass	3035	3038	_	_
20	20	not	not	RB	21	neg	3039	3042	_	_
20	21	destroyed	destroy	VBN	5	advcl	3043	3052	_	_
20	22	in	in	IN	24	case	3053	3055	_	_
20	23	the	the	DT	24	det	3056	3059	_	_
20	24	thymus	thymus	NN	21	nmod	3060	3066	_	_
20	25	are	be	VBP	27	auxpass	3067	3070	_	_
20	26	somehow	somehow	RB	27	advmod	3071	3078	_	_
20	27	prevented	prevent	VBN	24	acl:relcl	3079	3088	_	_
20	28	from	from	IN	29	mark	3089	3093	_	_
20	29	causing	cause	VBG	27	advcl	3094	3101	_	_
20	30	an	a	DT	32	det	3102	3104	_	_
20	31	autoimmune	autoimmune	JJ	32	amod	3105	3115	_	_
20	32	reaction	reaction	NN	29	dobj	3116	3124	_	_
20	33	.	.	.	5	punct	3124	3125	_	_

21	1	Although	although	IN	3	mark	3126	3134	_	_
21	2	studies	study	NNS	3	nsubj	3135	3142	_	_
21	3	suggest	suggest	VBP	23	advcl	3143	3150	_	_
21	4	that	that	IN	7	mark	3151	3155	_	_
21	5	peripheral	peripheral	JJ	6	amod	3156	3166	_	_
21	6	tolerance	tolerance	NN	7	nsubj	3167	3176	_	_
21	7	exists	exist	VBZ	3	ccomp	3177	3183	_	_
21	8	,	,	,	23	punct	3183	3184	_	_
21	9	at	at	IN	13	advmod	3185	3187	_	_
21	10	least	least	JJS	9	mwe	3188	3193	_	_
21	11	in	in	IN	13	case	3194	3196	_	_
21	12	experimental	experimental	JJ	13	amod	3197	3209	_	_
21	13	animals	animal	NNS	23	nmod	3210	3217	_	_
21	14	,	,	,	23	punct	3217	3218	_	_
21	15	the	the	DT	16	det	3219	3222	_	_
21	16	mechanism	mechanism	NN	23	nsubjpass	3223	3232	_	_
21	17	for	for	IN	19	case	3233	3236	_	_
21	18	the	the	DT	19	det	3237	3240	_	_
21	19	process	process	NN	16	nmod	3241	3248	_	_
21	20	is	be	VBZ	23	auxpass	3249	3251	_	_
21	21	not	not	RB	23	neg	3252	3255	_	_
21	22	yet	yet	RB	23	advmod	3256	3259	_	_
21	23	known	know	VBN	0	ROOT	3260	3265	_	_
21	24	.	.	.	23	punct	3265	3266	_	_

22	1	If	if	IN	4	mark	3267	3269	_	_
22	2	peripheral	peripheral	JJ	3	amod	3270	3280	_	_
22	3	tolerance	tolerance	NN	4	nsubj	3281	3290	_	_
22	4	exists	exist	VBZ	12	advcl	3291	3297	_	_
22	5	in	in	IN	6	case	3298	3300	_	_
22	6	people	people	NNS	4	nmod	3301	3307	B-persongroup-7146	_
22	7	,	,	,	12	punct	3307	3308	I-persongroup-7146	_
22	8	an	a	DT	10	det	3309	3311	_	_
22	9	autoimmune	autoimmune	JJ	10	amod	3312	3322	_	_
22	10	response	response	NN	12	nsubj	3323	3331	_	_
22	11	might	might	MD	12	aux	3332	3337	_	_
22	12	occur	occur	VB	0	ROOT	3338	3343	_	_
22	13	in	in	IN	14	case	3344	3346	_	_
22	14	response	response	NN	12	nmod	3347	3355	_	_
22	15	to	to	TO	16	case	3356	3358	_	_
22	16	vaccination	vaccination	NN	12	nmod	3359	3370	_	_
22	17	if	if	IN	21	mark	3371	3373	_	_
22	18	the	the	DT	19	det	3374	3377	_	_
22	19	vaccine	vaccine	NN	21	nsubj	3378	3385	_	_
22	20	somehow	somehow	RB	21	advmod	3386	3393	_	_
22	21	disrupts	disrupt	VBZ	12	advcl	3394	3402	_	_
22	22	that	that	IN	24	case	3403	3407	_	_
22	23	peripheral	peripheral	JJ	24	amod	3408	3418	_	_
22	24	tolerance	tolerance	NN	21	nmod	3419	3428	_	_
22	25	or	or	CC	21	cc	3429	3431	_	_
22	26	if	if	IN	31	mark	3432	3434	_	_
22	27	peripheral	peripheral	JJ	28	amod	3435	3445	_	_
22	28	tolerance	tolerance	NN	31	nsubj	3446	3455	_	_
22	29	is	be	VBZ	31	cop	3456	3458	_	_
22	30	not	not	RB	31	neg	3459	3462	_	_
22	31	strong	strong	JJ	21	conj	3463	3469	_	_
22	32	on	on	IN	34	case	3470	3472	_	_
22	33	the	the	DT	34	det	3473	3476	_	_
22	34	day	day	NN	31	nmod	3477	3480	_	_
22	35	of	of	IN	38	case	3481	3483	_	_
22	36	vaccination	vaccination	NN	38	compound	3484	3495	_	_
22	37	(	(	CD	38	nummod	3496	3497	_	_
22	38	Miller	Miller	NNP	34	nmod	3497	3503	B-persongroup-7147	_
22	39	et	et	FW	40	compound	3504	3506	_	_
22	40	al.	al.	FW	38	dep	3507	3510	_	_
22	41	,	,	,	38	punct	3510	3511	_	_
22	42	1989	1989	CD	43	nummod	3512	3516	_	_
22	43	)	)	NN	38	appos	3516	3517	_	_
22	44	.	.	.	12	punct	3517	3518	_	_

23	1	Some	some	DT	2	det	3519	3523	B-persongroup-7148	_
23	2	people	people	NNS	4	nsubj	3524	3530	I-persongroup-7148	_
23	3	have	have	VBP	4	aux	3531	3535	_	_
23	4	suggested	suggest	VBN	0	ROOT	3536	3545	_	_
23	5	that	that	IN	8	mark	3546	3550	_	_
23	6	vaccines	vaccine	NNS	8	nsubj	3551	3559	_	_
23	7	can	can	MD	8	aux	3560	3563	_	_
23	8	stimulate	stimulate	VB	4	ccomp	3564	3573	_	_
23	9	autoimmune	autoimmune	JJ	10	amod	3574	3584	_	_
23	10	reactions	reaction	NNS	8	dobj	3585	3594	_	_
23	11	if	if	IN	19	mark	3595	3597	_	_
23	12	some	some	DT	19	nsubj	3598	3602	_	_
23	13	of	of	IN	16	case	3603	3605	_	_
23	14	the	the	DT	16	det	3606	3609	_	_
23	15	antigen	antigen	NN	16	compound	3610	3617	_	_
23	16	fragments	fragment	NNS	12	nmod	3618	3627	_	_
23	17	in	in	IN	18	case	3628	3630	_	_
23	18	vaccines	vaccine	NNS	16	nmod	3631	3639	_	_
23	19	resemble	resemble	VBP	8	advcl	3640	3648	_	_
23	20	a	a	DT	21	det	3649	3650	B-persongroup-7149	_
23	21	person	person	NN	23	nmod:poss	3651	3657	I-persongroup-7149	_
23	22	's	's	POS	21	case	3657	3659	I-persongroup-7149	_
23	23	self-antigens	self-antigen	NNS	19	xcomp	3660	3673	_	_
23	24	.	.	.	4	punct	3673	3674	_	_

24	1	However	however	RB	5	advmod	3675	3682	_	_
24	2	,	,	,	5	punct	3682	3683	_	_
24	3	it	it	PRP	5	nsubj	3684	3686	_	_
24	4	is	be	VBZ	5	cop	3687	3689	_	_
24	5	unclear	unclear	JJ	0	ROOT	3690	3697	_	_
24	6	why	why	WRB	18	advmod	3698	3701	_	_
24	7	an	a	DT	9	det	3702	3704	_	_
24	8	immune	immune	JJ	9	amod	3705	3711	_	_
24	9	system	system	NN	18	nsubj	3712	3718	_	_
24	10	that	that	WDT	12	nsubj	3719	3723	_	_
24	11	is	be	VBZ	12	cop	3724	3726	_	_
24	12	tolerant	tolerant	JJ	9	acl:relcl	3727	3735	_	_
24	13	of	of	IN	16	case	3736	3738	_	_
24	14	its	its	PRP$	16	nmod:poss	3739	3742	_	_
24	15	own	own	JJ	16	amod	3743	3746	_	_
24	16	self-antigens	self-antigen	NNS	12	nmod	3747	3760	_	_
24	17	would	would	MD	18	aux	3761	3766	_	_
24	18	respond	respond	VB	5	advcl	3767	3774	_	_
24	19	to	to	TO	21	case	3775	3777	_	_
24	20	a	a	DT	21	det	3778	3779	_	_
24	21	self-antigen	self-antigen	NN	18	nmod	3780	3792	_	_
24	22	mimic	mimic	VB	18	ccomp	3793	3798	_	_
24	23	in	in	IN	25	case	3799	3801	_	_
24	24	a	a	DT	25	det	3802	3803	_	_
24	25	vaccine	vaccine	NN	22	nmod	3804	3811	_	_
24	26	.	.	.	5	punct	3811	3812	_	_

25	1	Berkower	Berkower	NNP	2	nsubj	3813	3821	B-persongroup-7150	_
25	2	speculated	speculate	VBD	0	ROOT	3822	3832	_	_
25	3	that	that	IN	6	mark	3833	3837	_	_
25	4	vaccines	vaccine	NNS	6	nsubj	3838	3846	_	_
25	5	might	might	MD	6	aux	3847	3852	_	_
25	6	counter	counter	VB	2	ccomp	3853	3860	_	_
25	7	peripheral	peripheral	JJ	8	amod	3861	3871	_	_
25	8	tolerance	tolerance	NN	6	dobj	3872	3881	_	_
25	9	and	and	CC	6	cc	3882	3885	_	_
25	10	foster	foster	VB	6	conj	3886	3892	_	_
25	11	an	a	DT	13	det	3893	3895	_	_
25	12	autoimmune	autoimmune	JJ	13	amod	3896	3906	_	_
25	13	reaction	reaction	NN	10	dobj	3907	3915	_	_
25	14	if	if	IN	16	mark	3916	3918	_	_
25	15	they	they	PRP	16	nsubj	3919	3923	_	_
25	16	contain	contain	VBP	10	advcl	3924	3931	_	_
25	17	molecular	molecular	JJ	18	amod	3932	3941	_	_
25	18	mimics	mimic	NNS	16	dobj	3942	3948	_	_
25	19	of	of	IN	20	case	3949	3951	_	_
25	20	self-antigens	self-antigen	NNS	18	nmod	3952	3965	_	_
25	21	that	that	WDT	25	nsubjpass	3966	3970	_	_
25	22	are	be	VBP	25	auxpass	3971	3974	_	_
25	23	usually	usually	RB	25	advmod	3975	3982	_	_
25	24	not	not	RB	25	neg	3983	3986	_	_
25	25	exposed	expose	VBN	20	acl:relcl	3987	3994	_	_
25	26	to	to	TO	28	case	3995	3997	_	_
25	27	T	t	NN	28	compound	3998	3999	_	_
25	28	cells	cell	NNS	25	nmod	4000	4005	_	_
25	29	,	,	,	28	punct	4005	4006	_	_
25	30	because	because	IN	33	mark	4007	4014	_	_
25	31	peripheral	peripheral	JJ	32	amod	4015	4025	_	_
25	32	tolerance	tolerance	NN	33	nsubj	4026	4035	_	_
25	33	seems	seem	VBZ	28	acl:relcl	4036	4041	_	_
25	34	to	to	TO	35	mark	4042	4044	_	_
25	35	depend	depend	VB	33	xcomp	4045	4051	_	_
25	36	on	on	IN	39	case	4052	4054	_	_
25	37	the	the	DT	39	det	4055	4058	_	_
25	38	continuous	continuous	JJ	39	amod	4059	4069	_	_
25	39	presence	presence	NN	35	nmod	4070	4078	_	_
25	40	of	of	IN	42	case	4079	4081	_	_
25	41	an	a	DT	42	det	4082	4084	_	_
25	42	antigen	antigen	NN	39	nmod	4085	4092	_	_
25	43	.	.	.	2	punct	4092	4093	_	_

26	1	Nakhasi	nakhasi	NN	2	nsubj	4094	4101	B-persongroup-7151	_
26	2	suggested	suggest	VBD	0	ROOT	4102	4111	_	_
26	3	that	that	IN	9	mark	4112	4116	_	_
26	4	an	a	DT	6	det	4117	4119	_	_
26	5	autoimmune	autoimmune	JJ	6	amod	4120	4130	_	_
26	6	response	response	NN	9	nsubjpass	4131	4139	_	_
26	7	might	might	MD	9	aux	4140	4145	_	_
26	8	be	be	VB	9	auxpass	4146	4148	_	_
26	9	instigated	instigate	VBN	2	ccomp	4149	4159	_	_
26	10	by	by	IN	12	case	4160	4162	_	_
26	11	a	a	DT	12	det	4163	4164	_	_
26	12	vaccine	vaccine	NN	9	nmod	4165	4172	_	_
26	13	or	or	CC	12	cc	4173	4175	_	_
26	14	by	by	IN	16	case	4176	4178	_	_
26	15	natural	natural	JJ	16	amod	4179	4186	_	_
26	16	infection	infection	NN	12	conj	4187	4196	_	_
26	17	if	if	IN	21	mark	4197	4199	_	_
26	18	the	the	DT	20	det	4200	4203	_	_
26	19	microbial	microbial	JJ	20	amod	4204	4213	_	_
26	20	antigens	antigen	NNS	21	nsubj	4214	4222	_	_
26	21	bind	bind	VBP	9	advcl	4223	4227	_	_
26	22	to	to	TO	23	case	4228	4230	_	_
26	23	self-antigens	self-antigen	NNS	21	nmod	4231	4244	_	_
26	24	in	in	IN	26	case	4245	4247	_	_
26	25	infected	infected	JJ	26	amod	4248	4256	_	_
26	26	cells	cell	NNS	23	nmod	4257	4262	_	_
26	27	and	and	CC	9	cc	4263	4266	_	_
26	28	change	change	VB	9	conj	4267	4273	_	_
26	29	the	the	DT	30	det	4274	4277	_	_
26	30	antigens	antigen	NNS	32	nmod:poss	4278	4286	_	_
26	31	'	'	POS	30	case	4286	4287	_	_
26	32	shape	shape	NN	28	dobj	4288	4293	_	_
26	33	such	such	JJ	32	amod	4294	4298	_	_
26	34	that	that	IN	39	mark	4299	4303	_	_
26	35	they	they	PRP	39	nsubjpass	4304	4308	_	_
26	36	are	be	VBP	39	auxpass	4309	4312	_	_
26	37	no	no	RB	38	neg	4313	4315	_	_
26	38	longer	longer	RB	39	advmod	4316	4322	_	_
26	39	tolerated	tolerate	VBN	28	ccomp	4323	4332	_	_
26	40	and	and	CC	2	cc	4333	4336	_	_
26	41	can	can	MD	42	aux	4337	4340	_	_
26	42	elicit	elicit	VB	2	conj	4341	4347	_	_
26	43	an	a	DT	45	det	4348	4350	_	_
26	44	immune	immune	JJ	45	amod	4351	4357	_	_
26	45	response	response	NN	42	dobj	4358	4366	_	_
26	46	.	.	.	2	punct	4366	4367	_	_

27	1	According	accord	VBG	3	case	4368	4377	_	_
27	2	to	to	TO	1	mwe	4378	4380	_	_
27	3	McFarland	McFarland	NNP	6	nmod	4381	4390	B-persongroup-7152	_
27	4	,	,	,	6	punct	4390	4391	I-persongroup-7152	_
27	5	researchers	researcher	NNS	6	nsubj	4392	4403	B-persongroup-7153	_
27	6	suspect	suspect	VBP	0	ROOT	4404	4411	_	_
27	7	that	that	IN	22	mark	4412	4416	_	_
27	8	molecular	molecular	JJ	9	amod	4417	4426	_	_
27	9	mimicry	mimicry	NN	22	nsubj	4427	4434	_	_
27	10	,	,	,	9	punct	4434	4435	_	_
27	11	which	which	WDT	14	nsubj	4436	4441	_	_
27	12	could	could	MD	14	aux	4442	4447	_	_
27	13	possibly	possibly	RB	14	advmod	4448	4456	_	_
27	14	lead	lead	VB	9	acl:relcl	4457	4461	_	_
27	15	to	to	TO	18	case	4462	4464	_	_
27	16	an	a	DT	18	det	4465	4467	_	_
27	17	autoimmune	autoimmune	JJ	18	amod	4468	4478	_	_
27	18	disorder	disorder	NN	14	nmod	4479	4487	_	_
27	19	,	,	,	9	punct	4487	4488	_	_
27	20	might	might	MD	22	aux	4489	4494	_	_
27	21	be	be	VB	22	aux	4495	4497	_	_
27	22	occurring	occur	VBG	6	ccomp	4498	4507	_	_
27	23	between	between	IN	24	case	4508	4515	_	_
27	24	self-antigens	self-antigen	NNS	22	nmod	4516	4529	_	_
27	25	and	and	CC	24	cc	4530	4533	_	_
27	26	antigens	antigen	NNS	24	conj	4534	4542	_	_
27	27	from	from	IN	28	case	4543	4547	_	_
27	28	microbes	microbe	NNS	24	nmod	4548	4556	_	_
27	29	or	or	CC	28	cc	4557	4559	_	_
27	30	vaccines	vaccine	NNS	28	conj	4560	4568	_	_
27	31	if	if	IN	35	mark	4569	4571	_	_
27	32	the	the	DT	34	det	4572	4575	_	_
27	33	two	two	CD	34	nummod	4576	4579	_	_
27	34	antigens	antigen	NNS	35	nsubj	4580	4588	_	_
27	35	share	share	VBP	22	advcl	4589	4594	_	_
27	36	much	much	JJ	35	dobj	4595	4599	_	_
27	37	of	of	IN	41	case	4600	4602	_	_
27	38	the	the	DT	41	det	4603	4606	_	_
27	39	same	same	JJ	41	amod	4607	4611	_	_
27	40	chemical	chemical	NN	41	compound	4612	4620	_	_
27	41	structure	structure	NN	36	nmod	4621	4630	_	_
27	42	.	.	.	6	punct	4630	4631	_	_

28	1	Recent	recent	JJ	2	amod	4632	4638	_	_
28	2	studies	study	NNS	3	nsubj	4639	4646	_	_
28	3	suggest	suggest	VBP	0	ROOT	4647	4654	_	_
28	4	,	,	,	3	punct	4654	4655	_	_
28	5	however	however	RB	3	advmod	4656	4663	_	_
28	6	,	,	,	3	punct	4663	4664	_	_
28	7	that	that	IN	9	mark	4665	4669	_	_
28	8	they	they	PRP	9	nsubj	4670	4674	_	_
28	9	need	need	VBP	3	ccomp	4675	4679	_	_
28	10	to	to	TO	11	mark	4680	4682	_	_
28	11	have	have	VB	9	xcomp	4683	4687	_	_
28	12	a	a	DT	14	det	4688	4689	_	_
28	13	similar	similar	JJ	14	amod	4690	4697	_	_
28	14	structure	structure	NN	11	dobj	4698	4707	_	_
28	15	only	only	RB	19	advmod	4708	4712	_	_
28	16	in	in	IN	19	case	4713	4715	_	_
28	17	the	the	DT	19	det	4716	4719	_	_
28	18	narrow	narrow	JJ	19	amod	4720	4726	_	_
28	19	region	region	NN	11	nmod	4727	4733	_	_
28	20	that	that	WDT	21	nsubj	4734	4738	_	_
28	21	binds	bind	VBZ	19	acl:relcl	4739	4744	_	_
28	22	to	to	TO	24	case	4745	4747	_	_
28	23	the	the	DT	24	det	4748	4751	_	_
28	24	T-cell	t-cell	NN	21	nmod	4752	4758	_	_
28	25	receptor	receptor	NN	27	compound	4759	4767	_	_
28	26	(	(	CD	27	nummod	4768	4769	_	_
28	27	Vogt	Vogt	NNP	24	dep	4769	4773	B-persongroup-7154	_
28	28	et	et	FW	29	compound	4774	4776	_	_
28	29	al.	al.	FW	24	dep	4777	4780	_	_
28	30	,	,	,	29	punct	4780	4781	_	_
28	31	1994	1994	CD	29	amod	4782	4786	_	_
28	32	;	;	:	29	punct	4786	4787	_	_
28	33	Wucherpfennig	Wucherpfennig	NNP	29	dep	4788	4801	B-persongroup-7155	_
28	34	et	et	FW	35	compound	4802	4804	_	_
28	35	al.	al.	FW	33	dep	4805	4808	_	_
28	36	,	,	,	24	punct	4808	4809	_	_
28	37	1994	1994	CD	38	nummod	4810	4814	_	_
28	38	)	)	NN	24	appos	4814	4815	_	_
28	39	.	.	.	3	punct	4815	4816	_	_

29	1	In	in	IN	2	case	4817	4819	_	_
29	2	addition	addition	NN	12	nmod	4820	4828	_	_
29	3	,	,	,	12	punct	4828	4829	_	_
29	4	the	the	DT	6	det	4830	4833	_	_
29	5	amino	amino	NN	6	compound	4834	4839	_	_
29	6	acids	acid	NNS	12	nsubj	4840	4845	_	_
29	7	in	in	IN	9	case	4846	4848	_	_
29	8	this	this	DT	9	det	4849	4853	_	_
29	9	region	region	NN	6	nmod	4854	4860	_	_
29	10	do	do	VBP	12	aux	4861	4863	_	_
29	11	not	not	RB	12	neg	4864	4867	_	_
29	12	have	have	VB	31	dep	4868	4872	_	_
29	13	to	to	TO	15	mark	4873	4875	_	_
29	14	be	be	VB	15	cop	4876	4878	_	_
29	15	identical	identical	JJ	12	xcomp	4879	4888	_	_
29	16	;	;	:	12	punct	4888	4889	_	_
29	17	rather	rather	RB	19	advmod	4890	4896	_	_
29	18	studies	study	NNS	19	nsubj	4897	4904	_	_
29	19	suggest	suggest	VBP	12	parataxis	4905	4912	_	_
29	20	that	that	IN	23	mark	4913	4917	_	_
29	21	they	they	PRP	23	nsubj	4918	4922	_	_
29	22	must	must	MD	23	aux	4923	4927	_	_
29	23	have	have	VB	19	ccomp	4928	4932	_	_
29	24	the	the	DT	27	det	4933	4936	_	_
29	25	same	same	JJ	27	amod	4937	4941	_	_
29	26	basic	basic	JJ	27	amod	4942	4947	_	_
29	27	chemical	chemical	NN	23	dobj	4948	4956	_	_
29	28	and	and	CC	27	cc	4957	4960	_	_
29	29	charge	charge	NN	30	compound	4961	4967	_	_
29	30	properties	property	NNS	27	conj	4968	4978	_	_
29	31	(	(	VBD	0	ROOT	4979	4980	_	_
29	32	Vogt	Vogt	NNP	31	dobj	4980	4984	B-persongroup-7156	_
29	33	et	et	FW	34	compound	4985	4987	_	_
29	34	al.	al.	FW	31	nsubj	4988	4991	_	_
29	35	,	,	,	34	punct	4991	4992	_	_
29	36	1994	1994	CD	34	amod	4993	4997	_	_
29	37	;	;	:	34	punct	4997	4998	_	_
29	38	Wucherpfennig	Wucherpfennig	NNP	34	dep	4999	5012	B-persongroup-7157	_
29	39	et	et	FW	40	compound	5013	5015	_	_
29	40	al.	al.	FW	38	dep	5016	5019	_	_
29	41	,	,	,	40	punct	5019	5020	_	_
29	42	1994	1994	CD	40	amod	5021	5025	_	_
29	43	;	;	:	34	punct	5025	5026	_	_
29	44	Vergelli	Vergelli	NNP	34	dep	5027	5035	B-persongroup-7158	_
29	45	et	et	FW	46	compound	5036	5038	_	_
29	46	al.	al.	FW	44	dep	5039	5042	_	_
29	47	,	,	,	34	punct	5042	5043	_	_
29	48	1996	1996	CD	49	nummod	5044	5048	_	_
29	49	)	)	NN	34	appos	5048	5049	_	_
29	50	.	.	.	31	punct	5049	5050	_	_

30	1	Some	some	DT	2	det	5051	5055	B-persongroup-7159	_
30	2	researchers	researcher	NNS	4	nsubj	5056	5067	I-persongroup-7159	_
30	3	have	have	VBP	4	aux	5068	5072	_	_
30	4	hypothesized	hypothesize	VBN	0	ROOT	5073	5085	_	_
30	5	that	that	IN	10	mark	5086	5090	_	_
30	6	autoimmune	autoimmune	JJ	7	amod	5091	5101	_	_
30	7	diseases	disease	NNS	10	nsubjpass	5102	5110	_	_
30	8	may	may	MD	10	aux	5111	5114	_	_
30	9	be	be	VB	10	auxpass	5115	5117	_	_
30	10	stimulated	stimulate	VBN	4	ccomp	5118	5128	_	_
30	11	by	by	IN	12	case	5129	5131	_	_
30	12	viruses	virus	NNS	10	nmod	5132	5139	_	_
30	13	(	(	CD	14	nummod	5140	5141	_	_
30	14	Fujinami	Fujinami	NNP	12	dep	5141	5149	B-persongroup-7160	_
30	15	et	et	FW	16	compound	5150	5152	_	_
30	16	al.	al.	FW	12	dep	5153	5156	_	_
30	17	,	,	,	16	punct	5156	5157	_	_
30	18	1985	1985	CD	16	conj	5158	5162	_	_
30	19	;	;	:	16	punct	5162	5163	_	_
30	20	Westall	Westall	NNP	16	conj	5164	5171	B-persongroup-7161	_
30	21	and	and	CC	16	cc	5172	5175	_	_
30	22	Root-Bernstein	Root-Bernstein	NNP	16	conj	5176	5190	B-persongroup-7162	_
30	23	,	,	,	12	punct	5190	5191	I-persongroup-7162	_
30	24	1983	1983	CD	25	nummod	5192	5196	_	_
30	25	)	)	NN	12	appos	5196	5197	_	_
30	26	.	.	.	4	punct	5197	5198	_	_

31	1	Westall	Westall	NNP	5	nsubj	5199	5206	B-persongroup-7163	_
31	2	and	and	CC	1	cc	5207	5210	_	_
31	3	Root-Bernstein	Root-Bernstein	NNP	1	conj	5211	5225	B-persongroup-7164	_
31	4	have	have	VBP	5	aux	5226	5230	_	_
31	5	postulated	postulate	VBN	0	ROOT	5231	5241	_	_
31	6	that	that	IN	9	mark	5242	5246	_	_
31	7	this	this	DT	9	nsubj	5247	5251	_	_
31	8	may	may	MD	9	aux	5252	5255	_	_
31	9	occur	occur	VB	5	ccomp	5256	5261	_	_
31	10	if	if	IN	14	mark	5262	5264	_	_
31	11	three	three	CD	12	nummod	5265	5270	_	_
31	12	criteria	criterion	NNS	14	nsubjpass	5271	5279	_	_
31	13	are	be	VBP	14	auxpass	5280	5283	_	_
31	14	met	meet	VBN	9	advcl	5284	5287	_	_
31	15	.	.	.	5	punct	5287	5288	_	_

32	1	The	the	DT	3	det	5289	5292	_	_
32	2	first	first	JJ	3	amod	5293	5298	_	_
32	3	one	one	CD	4	nsubj	5299	5302	_	_
32	4	is	be	VBZ	0	ROOT	5303	5305	_	_
32	5	that	that	IN	8	mark	5306	5310	_	_
32	6	antigens	antigen	NNS	8	nsubj	5311	5319	_	_
32	7	are	be	VBP	8	cop	5320	5323	_	_
32	8	present	present	JJ	4	ccomp	5324	5331	_	_
32	9	that	that	WDT	10	nsubj	5332	5336	_	_
32	10	have	have	VBP	8	ccomp	5337	5341	_	_
32	11	molecular	molecular	JJ	12	amod	5342	5351	_	_
32	12	structure	structure	NN	10	dobj	5352	5361	_	_
32	13	similar	similar	JJ	12	amod	5362	5369	_	_
32	14	to	to	TO	16	case	5370	5372	_	_
32	15	self	self	NN	16	compound	5373	5377	_	_
32	16	antigens	antigen	NNS	13	nmod	5378	5386	_	_
32	17	found	find	VBN	16	acl	5387	5392	_	_
32	18	in	in	IN	21	case	5393	5395	_	_
32	19	certain	certain	JJ	21	amod	5396	5403	_	_
32	20	human	human	JJ	21	amod	5404	5409	_	_
32	21	tissue	tissue	NN	17	nmod	5410	5416	_	_
32	22	(	(	CD	23	nummod	5417	5418	_	_
32	23	Westall	Westall	NNP	21	dep	5418	5425	B-persongroup-7165	_
32	24	and	and	CC	21	cc	5426	5429	_	_
32	25	Root	root	NN	21	conj	5430	5434	B-persongroup-7166	_
32	26	-	-	:	21	punct	5434	5435	I-persongroup-7166	_
32	27	Bernstein	Bernstein	NNP	21	conj	5436	5445	I-persongroup-7166	_
32	28	,	,	,	21	punct	5445	5446	I-persongroup-7166	_
32	29	1983	1983	CD	30	nummod	5447	5451	_	_
32	30	)	)	NN	21	conj	5451	5452	_	_
32	31	.	.	.	4	punct	5452	5453	_	_

33	1	The	the	DT	3	det	5454	5457	_	_
33	2	second	second	JJ	3	amod	5458	5464	_	_
33	3	one	one	CD	4	nsubj	5465	5468	_	_
33	4	is	be	VBZ	0	ROOT	5469	5471	_	_
33	5	that	that	IN	22	mark	5472	5476	_	_
33	6	an	a	DT	7	det	5477	5479	_	_
33	7	adjuvant	adjuvant	JJ	22	nsubj	5480	5488	_	_
33	8	derived	derive	VBN	7	acl	5489	5496	_	_
33	9	from	from	IN	10	case	5497	5501	_	_
33	10	walls	wall	NNS	8	nmod	5502	5507	_	_
33	11	of	of	IN	14	case	5508	5510	_	_
33	12	the	the	DT	14	det	5511	5514	_	_
33	13	bacterial	bacterial	JJ	14	amod	5515	5524	_	_
33	14	cells	cell	NNS	10	nmod	5525	5530	_	_
33	15	used	use	VBN	14	acl	5531	5535	_	_
33	16	in	in	IN	20	case	5536	5538	_	_
33	17	the	the	DT	18	det	5539	5542	_	_
33	18	vaccine	vaccine	NN	20	nmod:poss	5543	5550	_	_
33	19	's	's	POS	18	case	5550	5552	_	_
33	20	manufacture	manufacture	NN	15	nmod	5553	5564	_	_
33	21	is	be	VBZ	22	cop	5565	5567	_	_
33	22	present	present	JJ	4	ccomp	5568	5575	_	_
33	23	.	.	.	4	punct	5575	5576	_	_

34	1	The	the	DT	3	det	5577	5580	_	_
34	2	third	third	JJ	3	amod	5581	5586	_	_
34	3	one	one	CD	4	nsubj	5587	5590	_	_
34	4	is	be	VBZ	0	ROOT	5591	5593	_	_
34	5	that	that	IN	10	mark	5594	5598	_	_
34	6	antigens	antigen	NNS	10	nsubj	5599	5607	_	_
34	7	exhibiting	exhibit	VBG	6	acl	5608	5618	_	_
34	8	complimentarity	complimentarity	NN	7	dobj	5619	5634	_	_
34	9	are	be	VBP	10	cop	5635	5638	_	_
34	10	present	present	JJ	4	ccomp	5639	5646	_	_
34	11	.	.	.	4	punct	5646	5647	_	_

35	1	When	when	WRB	6	advmod	5648	5652	_	_
35	2	these	these	DT	4	det	5653	5658	_	_
35	3	three	three	CD	4	nummod	5659	5664	_	_
35	4	criteria	criterion	NNS	6	nsubj	5665	5673	_	_
35	5	are	be	VBP	6	cop	5674	5677	_	_
35	6	present	present	JJ	13	advcl	5678	5685	_	_
35	7	an	a	DT	9	det	5686	5688	_	_
35	8	antigenic	antigenic	JJ	9	amod	5689	5698	_	_
35	9	challenge	challenge	NN	13	nsubj	5699	5708	_	_
35	10	to	to	TO	12	case	5709	5711	_	_
35	11	the	the	DT	12	det	5712	5715	B-persongroup-7167	_
35	12	host	host	NN	9	nmod	5716	5720	I-persongroup-7167	_
35	13	evokes	evoke	VBZ	0	ROOT	5721	5727	_	_
35	14	autoimmunity	autoimmunity	NN	13	dobj	5728	5740	_	_
35	15	.	.	.	13	punct	5740	5741	_	_

36	1	This	this	DT	2	det	5742	5746	_	_
36	2	hypothesis	hypothesis	NN	5	nsubjpass	5747	5757	_	_
36	3	has	have	VBZ	5	aux	5758	5761	_	_
36	4	been	be	VBN	5	auxpass	5762	5766	_	_
36	5	named	name	VBN	0	ROOT	5767	5772	_	_
36	6	Multiple-Antigen-Mediated-Autoimmunity	multiple-antigen-mediated-autoimmunity	JJ	10	amod	5773	5811	_	_
36	7	(	(	NN	10	compound	5812	5813	_	_
36	8	MAMA	mama	NN	10	compound	5813	5817	_	_
36	9	)	)	CD	10	nummod	5817	5818	_	_
36	10	Syndrome	syndrome	NN	5	dobj	5819	5827	_	_
36	11	.	.	.	5	punct	5827	5828	_	_

37	1	Root-Bernstein	Root-Bernstein	NNP	3	nsubj	5829	5843	B-persongroup-7168	_
37	2	has	have	VBZ	3	aux	5844	5847	_	_
37	3	presented	present	VBN	0	ROOT	5848	5857	_	_
37	4	evidence	evidence	NN	3	dobj	5858	5866	_	_
37	5	that	that	IN	7	mark	5867	5871	_	_
37	6	it	it	PRP	7	nsubj	5872	5874	_	_
37	7	exists	exist	VBZ	3	ccomp	5875	5881	_	_
37	8	in	in	IN	10	case	5882	5884	_	_
37	9	AIDS	aids	NN	10	compound	5885	5889	B-persongroup-7171	_
37	10	patients	patient	NNS	7	nmod	5890	5898	I-persongroup-7171	_
37	11	who	who	WP	12	nsubj	5899	5902	I-persongroup-7171	_
37	12	develop	develop	VBP	10	acl:relcl	5903	5910	I-persongroup-7171	_
37	13	encephalomyelitis	encephalomyelitis	NN	15	compound	5911	5928	I-persongroup-7171	_
37	14	(	(	CD	15	nummod	5929	5930	_	_
37	15	Sela	Sela	NNP	12	dobj	5930	5934	B-persongroup-7169	_
37	16	and	and	CC	15	cc	5935	5938	_	_
37	17	Arnon	Arnon	NNP	15	conj	5939	5944	B-persongroup-7170	_
37	18	,	,	,	17	punct	5944	5945	I-persongroup-7170	_
37	19	1992	1992	CD	20	nummod	5946	5950	_	_
37	20	)	)	NN	17	appos	5950	5951	_	_
37	21	.	.	.	3	punct	5951	5952	_	_

38	1	Waisbren	Waisbren	NNP	2	nsubj	5953	5961	B-persongroup-7172	_
38	2	suggested	suggest	VBD	0	ROOT	5962	5971	_	_
38	3	that	that	IN	10	mark	5972	5976	_	_
38	4	the	the	DT	6	det	5977	5980	_	_
38	5	MAMA	MAMA	NNP	6	compound	5981	5985	_	_
38	6	Syndrome	syndrome	NN	10	nsubj	5986	5994	_	_
38	7	might	might	MD	10	aux	5995	6000	_	_
38	8	be	be	VB	10	cop	6001	6003	_	_
38	9	a	a	DT	10	det	6004	6005	_	_
38	10	mechanism	mechanism	NN	2	ccomp	6006	6015	_	_
38	11	that	that	WDT	12	nsubj	6016	6020	_	_
38	12	induces	induce	VBZ	10	acl:relcl	6021	6028	_	_
38	13	autoimmunity	autoimmunity	NN	12	dobj	6029	6041	_	_
38	14	in	in	IN	16	case	6042	6044	_	_
38	15	susceptible	susceptible	JJ	16	amod	6045	6056	B-persongroup-7173	_
38	16	individuals	individual	NNS	13	nmod	6057	6068	I-persongroup-7173	_
38	17	after	after	IN	18	case	6069	6074	_	_
38	18	vaccination	vaccination	NN	12	nmod	6075	6086	_	_
38	19	with	with	IN	21	case	6087	6091	_	_
38	20	virus	virus	NN	21	compound	6092	6097	_	_
38	21	components	component	NNS	18	nmod	6098	6108	_	_
38	22	that	that	WDT	25	nsubj	6109	6113	_	_
38	23	are	be	VBP	25	cop	6114	6117	_	_
38	24	also	also	RB	25	advmod	6118	6122	_	_
38	25	present	present	JJ	18	acl:relcl	6123	6130	_	_
38	26	in	in	IN	28	case	6131	6133	_	_
38	27	human	human	JJ	28	amod	6134	6139	_	_
38	28	tissue	tissue	NN	25	nmod	6140	6146	_	_
38	29	.	.	.	2	punct	6146	6147	_	_

39	1	These	these	DT	2	det	6148	6153	_	_
39	2	antigens	antigen	NNS	5	nsubjpass	6154	6162	_	_
39	3	may	may	MD	5	aux	6163	6166	_	_
39	4	be	be	VB	5	auxpass	6167	6169	_	_
39	5	associated	associate	VBN	0	ROOT	6170	6180	_	_
39	6	with	with	IN	10	case	6181	6185	_	_
39	7	other	other	JJ	10	amod	6186	6191	_	_
39	8	complimentary	complimentary	JJ	10	amod	6192	6205	_	_
39	9	viral	viral	JJ	10	amod	6206	6211	_	_
39	10	antigens	antigen	NNS	5	nmod	6212	6220	_	_
39	11	and	and	CC	10	cc	6221	6224	_	_
39	12	bacterial	bacterial	JJ	15	amod	6225	6234	_	_
39	13	cell	cell	NN	15	compound	6235	6239	_	_
39	14	wall	wall	NN	15	compound	6240	6244	_	_
39	15	components	component	NNS	10	conj	6245	6255	_	_
39	16	present	present	JJ	15	amod	6256	6263	_	_
39	17	in	in	IN	19	case	6264	6266	_	_
39	18	the	the	DT	19	det	6267	6270	B-persongroup-7174	_
39	19	patient	patient	NN	16	nmod	6271	6278	I-persongroup-7174	_
39	20	who	who	WP	23	nsubjpass	6279	6282	I-persongroup-7174	_
39	21	has	have	VBZ	23	aux	6283	6286	I-persongroup-7174	_
39	22	been	be	VBN	23	auxpass	6287	6291	I-persongroup-7174	_
39	23	vaccinated	vaccinate	VBN	19	acl:relcl	6292	6302	I-persongroup-7174	_
39	24	.	.	.	5	punct	6302	6303	I-persongroup-7174	_

40	1	Each	each	DT	2	det	6304	6308	_	_
40	2	year	year	NN	8	nsubjpass	6309	6313	_	_
40	3	about	about	IN	6	case	6314	6319	B-persongroup-7175	_
40	4	300,000	300,000	CD	6	nummod	6320	6327	I-persongroup-7175	_
40	5	premature	premature	JJ	6	amod	6328	6337	I-persongroup-7175	_
40	6	infants	infant	NNS	2	nmod	6338	6345	I-persongroup-7175	_
40	7	are	be	VBP	8	auxpass	6346	6349	_	_
40	8	born	bear	VBN	0	ROOT	6350	6354	_	_
40	9	in	in	IN	12	case	6355	6357	_	_
40	10	the	the	DT	12	det	6358	6361	B-persongroup-7176	_
40	11	United	United	NNP	12	compound	6362	6368	I-persongroup-7176	_
40	12	States	States	NNPS	8	nmod	6369	6375	I-persongroup-7176	_
40	13	,	,	,	8	punct	6375	6376	I-persongroup-7176	_
40	14	and	and	CC	8	cc	6377	6380	_	_
40	15	most	most	JJS	18	nsubj	6381	6385	B-persongroup-7177	_
40	16	of	of	IN	17	case	6386	6388	I-persongroup-7177	_
40	17	these	these	DT	15	nmod	6389	6394	I-persongroup-7177	_
40	18	survive	survive	VBP	8	conj	6395	6402	_	_
40	19	past	past	JJ	20	amod	6403	6407	_	_
40	20	infancy	infancy	NN	18	dobj	6408	6415	_	_
40	21	(	(	CD	22	nummod	6416	6417	_	_
40	22	Ventura	Ventura	NNP	20	dep	6417	6424	B-persongroup-7178	_
40	23	et	et	FW	24	compound	6425	6427	_	_
40	24	al.	al.	FW	18	nmod:tmod	6428	6431	_	_
40	25	,	,	,	24	punct	6431	6432	_	_
40	26	1996	1996	CD	27	nummod	6433	6437	_	_
40	27	)	)	NN	24	appos	6437	6438	_	_
40	28	.	.	.	8	punct	6438	6439	_	_

41	1	Preliminary	preliminary	JJ	2	amod	6440	6451	_	_
41	2	studies	study	NNS	3	nsubj	6452	6459	_	_
41	3	suggest	suggest	VBP	0	ROOT	6460	6467	_	_
41	4	that	that	IN	9	mark	6468	6472	_	_
41	5	premature	premature	JJ	8	amod	6473	6482	B-persongroup-7179	_
41	6	large	large	JJ	8	amod	6483	6488	I-persongroup-7179	_
41	7	birthweight	birthweight	JJ	8	amod	6489	6500	I-persongroup-7179	_
41	8	infants	infant	NNS	9	nsubj	6501	6508	I-persongroup-7179	_
41	9	have	have	VBP	3	ccomp	6509	6513	_	_
41	10	the	the	DT	14	det	6514	6517	_	_
41	11	same	same	JJ	14	amod	6518	6522	_	_
41	12	or	or	CC	11	cc	6523	6525	_	_
41	13	less	less	JJR	11	conj	6526	6530	_	_
41	14	risk	risk	NN	9	dobj	6531	6535	_	_
41	15	of	of	IN	16	mark	6536	6538	_	_
41	16	experiencing	experience	VBG	14	acl	6539	6551	_	_
41	17	the	the	DT	20	det	6552	6555	_	_
41	18	usual	usual	JJ	20	amod	6556	6561	_	_
41	19	adverse	adverse	JJ	20	amod	6562	6569	_	_
41	20	effects	effect	NNS	16	dobj	6570	6577	_	_
41	21	reported	report	VBN	20	acl	6578	6586	_	_
41	22	for	for	IN	24	case	6587	6590	_	_
41	23	full-term	full-term	JJ	24	amod	6591	6600	B-persongroup-7180	_
41	24	infants	infant	NNS	21	nmod	6601	6608	I-persongroup-7180	_
41	25	following	follow	VBG	26	case	6609	6618	_	_
41	26	vaccination	vaccination	NN	24	nmod	6619	6630	_	_
41	27	with	with	IN	32	case	6631	6635	_	_
41	28	HBV	hbv	NN	32	compound	6636	6639	_	_
41	29	or	or	CC	28	cc	6640	6642	_	_
41	30	DPT	DPT	NNP	28	conj	6643	6646	_	_
41	31	(	(	CD	32	nummod	6647	6648	_	_
41	32	Bernbaum	Bernbaum	NNP	26	nmod	6648	6656	B-persongroup-7181	_
41	33	et	et	FW	34	compound	6657	6659	_	_
41	34	al.	al.	FW	32	dep	6660	6663	_	_
41	35	,	,	,	32	punct	6663	6664	_	_
41	36	1989	1989	CD	32	appos	6665	6669	_	_
41	37	;	;	:	36	punct	6669	6670	_	_
41	38	Koblan	Koblan	NNP	36	dep	6671	6677	B-persongroup-7182	_
41	39	et	et	FW	40	compound	6678	6680	_	_
41	40	al.	al.	FW	38	dep	6681	6684	_	_
41	41	,	,	,	32	punct	6684	6685	_	_
41	42	1988	1988	CD	32	amod	6686	6690	_	_
41	43	;	;	:	32	punct	6690	6691	_	_
41	44	Ramsay	Ramsay	NNP	32	dep	6692	6698	B-persongroup-7183	_
41	45	et	et	FW	46	compound	6699	6701	_	_
41	46	al.	al.	FW	44	dep	6702	6705	_	_
41	47	,	,	,	32	punct	6705	6706	_	_
41	48	1995	1995	CD	32	amod	6707	6711	_	_
41	49	;	;	:	32	punct	6711	6712	_	_
41	50	Losonsky	Losonsky	NNP	32	dep	6713	6721	B-persongroup-7184	_
41	51	,	,	,	32	punct	6721	6722	I-persongroup-7184	_
41	52	unpublished	unpublished	JJ	54	amod	6723	6734	_	_
41	53	data	datum	NNS	54	compound	6735	6739	_	_
41	54	)	)	NN	32	appos	6739	6740	_	_
41	55	.	.	.	3	punct	6740	6741	_	_

42	1	However	however	RB	14	advmod	6742	6749	_	_
42	2	,	,	,	14	punct	6749	6750	_	_
42	3	recent	recent	JJ	4	amod	6751	6757	_	_
42	4	data	datum	NNS	14	nsubj	6758	6762	_	_
42	5	with	with	IN	7	case	6763	6767	_	_
42	6	DPT	DPT	NNP	7	compound	6768	6771	_	_
42	7	immunization	immunization	NN	4	nmod	6772	6784	_	_
42	8	in	in	IN	13	case	6785	6787	_	_
42	9	very	very	RB	13	advmod	6788	6792	B-persongroup-7185	_
42	10	low	low	JJ	13	amod	6793	6796	I-persongroup-7185	_
42	11	birth	birth	NN	13	compound	6797	6802	I-persongroup-7185	_
42	12	weight	weight	NN	13	compound	6803	6809	I-persongroup-7185	_
42	13	infants	infant	NNS	7	nmod	6810	6817	I-persongroup-7185	_
42	14	suggest	suggest	VBP	35	dep	6818	6825	_	_
42	15	that	that	IN	22	mark	6826	6830	_	_
42	16	moderate	moderate	JJ	18	amod	6831	6839	_	_
42	17	to	to	TO	18	dep	6840	6842	_	_
42	18	severe	severe	JJ	20	amod	6843	6849	_	_
42	19	adverse	adverse	JJ	20	amod	6850	6857	_	_
42	20	reactions	reaction	NNS	22	nsubj	6858	6867	_	_
42	21	can	can	MD	22	aux	6868	6871	_	_
42	22	occur	occur	VB	14	ccomp	6872	6877	_	_
42	23	following	follow	VBG	25	case	6878	6887	_	_
42	24	routine	routine	JJ	25	amod	6888	6895	_	_
42	25	vaccination	vaccination	NN	22	nmod	6896	6907	_	_
42	26	with	with	IN	27	case	6908	6912	_	_
42	27	DPT	DPT	NNP	25	nmod	6913	6916	_	_
42	28	in	in	IN	29	case	6917	6919	_	_
42	29	infants	infant	NNS	27	nmod	6920	6927	B-persongroup-7186	_
42	30	born	bear	VBN	29	acl	6928	6932	I-persongroup-7186	_
42	31	less	less	JJR	33	advmod	6933	6937	I-persongroup-7186	_
42	32	than	than	IN	31	mwe	6938	6942	I-persongroup-7186	_
42	33	1,000	1,000	CD	34	nummod	6943	6948	I-persongroup-7186	_
42	34	grams	gram	NNS	30	dobj	6949	6954	I-persongroup-7186	_
42	35	(	(	VBP	0	ROOT	6955	6956	_	_
42	36	Sudhakarow	Sudhakarow	NNP	35	dobj	6956	6966	B-persongroup-7187	_
42	37	et	et	FW	38	compound	6967	6969	_	_
42	38	al.	al.	FW	35	nsubj	6970	6973	_	_
42	39	,	,	,	38	punct	6973	6974	_	_
42	40	1996	1996	CD	41	nummod	6975	6979	_	_
42	41	)	)	NN	38	appos	6979	6980	_	_
42	42	.	.	.	35	punct	6980	6981	_	_

43	1	Routine	routine	JJ	2	amod	6982	6989	_	_
43	2	immunization	immunization	NN	8	nsubjpass	6990	7002	_	_
43	3	of	of	IN	6	case	7003	7005	_	_
43	4	extremely	extremely	RB	5	advmod	7006	7015	B-persongroup-7188	_
43	5	premature	premature	JJ	6	amod	7016	7025	I-persongroup-7188	_
43	6	infants	infant	NNS	2	nmod	7026	7033	I-persongroup-7188	_
43	7	is	be	VBZ	8	auxpass	7034	7036	_	_
43	8	associated	associate	VBN	0	ROOT	7037	7047	_	_
43	9	with	with	IN	12	case	7048	7052	_	_
43	10	significant	significant	JJ	12	amod	7053	7064	_	_
43	11	adverse	adverse	JJ	12	amod	7065	7072	_	_
43	12	events	event	NNS	8	nmod	7073	7079	_	_
43	13	.	.	.	8	punct	7079	7080	_	_

44	1	According	accord	VBG	3	case	7081	7090	_	_
44	2	to	to	TO	1	mwe	7091	7093	_	_
44	3	Losonsky	Losonsky	NNP	17	nmod	7094	7102	B-persongroup-7189	_
44	4	,	,	,	17	punct	7102	7103	I-persongroup-7189	_
44	5	larger	larger	JJR	6	amod	7104	7110	_	_
44	6	studies	study	NNS	17	nsubj	7111	7118	_	_
44	7	that	that	WDT	8	nsubj	7119	7123	_	_
44	8	cover	cover	VBP	6	acl:relcl	7124	7129	_	_
44	9	the	the	DT	11	det	7130	7133	_	_
44	10	full	full	JJ	11	amod	7134	7138	_	_
44	11	range	range	NN	8	dobj	7139	7144	_	_
44	12	of	of	IN	13	case	7145	7147	_	_
44	13	vaccines	vaccine	NNS	11	nmod	7148	7156	_	_
44	14	given	give	VBN	16	case	7157	7162	_	_
44	15	to	to	TO	16	case	7163	7165	_	_
44	16	infants	infant	NNS	8	advcl	7166	7173	B-persongroup-7190	_
44	17	need	need	VBP	0	ROOT	7174	7178	_	_
44	18	to	to	TO	20	mark	7179	7181	_	_
44	19	be	be	VB	20	auxpass	7182	7184	_	_
44	20	done	do	VBN	17	xcomp	7185	7189	_	_
44	21	to	to	TO	22	mark	7190	7192	_	_
44	22	assess	assess	VB	20	xcomp	7193	7199	_	_
44	23	the	the	DT	24	det	7200	7203	_	_
44	24	risk	risk	NN	22	dobj	7204	7208	_	_
44	25	of	of	IN	28	case	7209	7211	_	_
44	26	common	common	JJ	28	amod	7212	7218	_	_
44	27	adverse	adverse	JJ	28	amod	7219	7226	_	_
44	28	events	event	NNS	24	nmod	7227	7233	_	_
44	29	in	in	IN	31	case	7234	7236	_	_
44	30	premature	premature	JJ	31	amod	7237	7246	B-persongroup-7191	_
44	31	infants	infant	NNS	22	nmod	7247	7254	I-persongroup-7191	_
44	32	.	.	.	17	punct	7254	7255	I-persongroup-7191	_

45	1	Current	current	JJ	3	amod	7256	7263	_	_
45	2	vaccine	vaccine	NN	3	compound	7264	7271	_	_
45	3	schedules	schedule	NNS	5	nsubjpass	7272	7281	_	_
45	4	are	be	VBP	5	auxpass	7282	7285	_	_
45	5	based	base	VBN	0	ROOT	7286	7291	_	_
45	6	largely	largely	RB	5	advmod	7292	7299	_	_
45	7	on	on	IN	10	case	7300	7302	_	_
45	8	the	the	DT	10	det	7303	7306	_	_
45	9	immune	immune	JJ	10	amod	7307	7313	_	_
45	10	responses	response	NNS	5	nmod	7314	7323	_	_
45	11	seen	see	VBN	10	acl	7324	7328	_	_
45	12	in	in	IN	17	case	7329	7331	_	_
45	13	full-term	full-term	JJ	17	amod	7332	7341	B-persongroup-7192	_
45	14	rather	rather	RB	13	cc	7342	7348	_	_
45	15	than	than	IN	14	mwe	7349	7353	_	_
45	16	premature	premature	JJ	13	conj	7354	7363	B-persongroup-7193	_
45	17	infants	infant	NNS	11	nmod	7364	7371	I-persongroup-7192#I-persongroup-7193	_
45	18	.	.	.	5	punct	7371	7372	I-persongroup-7193	_

46	1	The	the	DT	4	det	7373	7376	_	_
46	2	human	human	JJ	4	amod	7377	7382	_	_
46	3	immune	immune	JJ	4	amod	7383	7389	_	_
46	4	system	system	NN	5	nsubj	7390	7396	_	_
46	5	matures	mature	VBZ	0	ROOT	7397	7404	_	_
46	6	throughout	throughout	IN	8	case	7405	7415	_	_
46	7	fetal	fetal	JJ	8	amod	7416	7421	_	_
46	8	life	life	NN	5	nmod	7422	7426	_	_
46	9	and	and	CC	5	cc	7427	7430	_	_
46	10	up	up	RB	26	advmod	7431	7433	_	_
46	11	until	until	IN	10	case	7434	7439	_	_
46	12	about	about	IN	14	case	7440	7445	_	_
46	13	2	2	CD	14	nummod	7446	7447	_	_
46	14	years	year	NNS	10	nmod	7448	7453	_	_
46	15	of	of	IN	16	case	7454	7456	_	_
46	16	age	age	NN	14	nmod	7457	7460	_	_
46	17	,	,	,	14	punct	7460	7461	_	_
46	18	however	however	RB	14	advmod	7462	7469	_	_
46	19	,	,	,	26	punct	7469	7470	_	_
46	20	so	so	RB	23	advmod	7471	7473	_	_
46	21	even	even	RB	23	advmod	7474	7478	_	_
46	22	full-term	full-term	JJ	23	amod	7479	7488	B-persongroup-7194	_
46	23	infants	infant	NNS	26	nsubj	7489	7496	I-persongroup-7194	_
46	24	do	do	VBP	26	aux	7497	7499	_	_
46	25	not	not	RB	26	neg	7500	7503	_	_
46	26	develop	develop	VB	5	conj	7504	7511	_	_
46	27	an	a	DT	31	det	7512	7514	_	_
46	28	adequate	adequate	JJ	31	amod	7515	7523	_	_
46	29	protective	protective	JJ	31	amod	7524	7534	_	_
46	30	immune	immune	JJ	31	amod	7535	7541	_	_
46	31	response	response	NN	26	dobj	7542	7550	_	_
46	32	to	to	TO	34	case	7551	7553	_	_
46	33	most	most	JJS	34	amod	7554	7558	_	_
46	34	vaccines	vaccine	NNS	26	nmod	7559	7567	_	_
46	35	administered	administer	VBN	34	acl	7568	7580	_	_
46	36	in	in	IN	39	case	7581	7583	_	_
46	37	the	the	DT	39	det	7584	7587	_	_
46	38	first	first	JJ	39	amod	7588	7593	_	_
46	39	weeks	week	NNS	35	nmod	7594	7599	_	_
46	40	of	of	IN	41	case	7600	7602	_	_
46	41	life	life	NN	39	nmod	7603	7607	_	_
46	42	.	.	.	5	punct	7607	7608	_	_

47	1	Losonsky	Losonsky	NNP	2	nsubj	7609	7617	B-persongroup-7195	_
47	2	expressed	express	VBD	0	ROOT	7618	7627	_	_
47	3	concern	concern	NN	2	dobj	7628	7635	_	_
47	4	that	that	IN	15	mark	7636	7640	_	_
47	5	premature	premature	JJ	6	amod	7641	7650	B-persongroup-7197	_
47	6	infants	infant	NNS	15	nsubj	7651	7658	I-persongroup-7197	_
47	7	given	give	VBN	6	acl	7659	7664	_	_
47	8	vaccines	vaccine	NNS	7	dobj	7665	7673	_	_
47	9	at	at	IN	12	case	7674	7676	_	_
47	10	the	the	DT	12	det	7677	7680	_	_
47	11	standard	standard	JJ	12	amod	7681	7689	_	_
47	12	times	time	NNS	7	nmod	7690	7695	_	_
47	13	may	may	MD	15	aux	7696	7699	_	_
47	14	not	not	RB	15	neg	7700	7703	_	_
47	15	develop	develop	VB	2	ccomp	7704	7711	_	_
47	16	adequate	adequate	JJ	17	amod	7712	7720	_	_
47	17	immunity	immunity	NN	15	dobj	7721	7729	_	_
47	18	to	to	TO	20	case	7730	7732	_	_
47	19	the	the	DT	20	det	7733	7736	_	_
47	20	diseases	disease	NNS	15	nmod	7737	7745	_	_
47	21	against	against	IN	26	mark	7746	7753	_	_
47	22	which	which	WDT	28	dobj	7754	7759	_	_
47	23	the	the	DT	24	det	7760	7763	_	_
47	24	vaccines	vaccine	NNS	26	nsubjpass	7764	7772	_	_
47	25	are	be	VBP	26	auxpass	7773	7776	_	_
47	26	designed	design	VBN	20	acl	7777	7785	_	_
47	27	to	to	TO	28	mark	7786	7788	_	_
47	28	protect	protect	VB	26	xcomp	7789	7796	_	_
47	29	.	.	.	2	punct	7796	7797	_	_

48	1	There	there	EX	2	expl	7798	7803	_	_
48	2	is	be	VBZ	0	ROOT	7804	7806	_	_
48	3	also	also	RB	2	advmod	7807	7811	_	_
48	4	speculation	speculation	NN	2	nsubj	7812	7823	_	_
48	5	that	that	IN	10	mark	7824	7828	_	_
48	6	some	some	DT	8	det	7829	7833	B-persongroup-7198	_
48	7	premature	premature	JJ	8	amod	7834	7843	I-persongroup-7198	_
48	8	infants	infant	NNS	10	nsubj	7844	7851	I-persongroup-7198	_
48	9	might	might	MD	10	aux	7852	7857	_	_
48	10	develop	develop	VB	2	ccomp	7858	7865	_	_
48	11	immunologic	immunologic	JJ	12	amod	7866	7877	_	_
48	12	tolerance	tolerance	NN	10	dobj	7878	7887	_	_
48	13	to	to	TO	18	case	7888	7890	_	_
48	14	the	the	DT	18	det	7891	7894	_	_
48	15	viral	viral	JJ	18	amod	7895	7900	_	_
48	16	or	or	CC	15	cc	7901	7903	_	_
48	17	bacterial	bacterial	JJ	15	conj	7904	7913	_	_
48	18	antigens	antigen	NNS	12	nmod	7914	7922	_	_
48	19	in	in	IN	20	case	7923	7925	_	_
48	20	vaccines	vaccine	NNS	12	nmod	7926	7934	_	_
48	21	such	such	JJ	10	advcl	7935	7939	_	_
48	22	that	that	IN	26	mark	7940	7944	_	_
48	23	they	they	PRP	26	nsubj	7945	7949	B-persongroup-7199	_
48	24	do	do	VBP	26	aux	7950	7952	_	_
48	25	not	not	RB	26	neg	7953	7956	_	_
48	26	develop	develop	VB	10	ccomp	7957	7964	_	_
48	27	an	a	DT	29	det	7965	7967	_	_
48	28	immune	immune	JJ	29	amod	7968	7974	_	_
48	29	response	response	NN	26	dobj	7975	7983	_	_
48	30	to	to	TO	32	case	7984	7986	_	_
48	31	subsequent	subsequent	JJ	32	amod	7987	7997	_	_
48	32	vaccines	vaccine	NNS	26	nmod	7998	8006	_	_
48	33	given	give	VBN	32	acl	8007	8012	_	_
48	34	later	later	RB	33	advmod	8013	8018	_	_
48	35	in	in	IN	36	case	8019	8021	_	_
48	36	life	life	NN	33	nmod	8022	8026	_	_
48	37	.	.	.	2	punct	8026	8027	_	_

49	1	According	accord	VBG	3	case	8028	8037	_	_
49	2	to	to	TO	1	mwe	8038	8040	_	_
49	3	Losonsky	Losonsky	NNP	10	nmod	8041	8049	B-persongroup-7200	_
49	4	,	,	,	10	punct	8049	8050	I-persongroup-7200	_
49	5	98	98	CD	6	nummod	8051	8053	B-persongroup-7201	_
49	6	percent	percent	NN	10	nsubj	8054	8061	I-persongroup-7201	_
49	7	of	of	IN	9	case	8062	8064	I-persongroup-7201	_
49	8	full-term	full-term	JJ	9	amod	8065	8074	I-persongroup-7201	_
49	9	infants	infant	NNS	6	nmod	8075	8082	I-persongroup-7201	_
49	10	achieve	achieve	VBP	0	ROOT	8083	8090	_	_
49	11	protective	protective	JJ	13	amod	8091	8101	_	_
49	12	immune	immune	JJ	13	amod	8102	8108	_	_
49	13	responses	response	NNS	10	dobj	8109	8118	_	_
49	14	after	after	IN	15	mark	8119	8124	_	_
49	15	receiving	receive	VBG	10	advcl	8125	8134	_	_
49	16	the	the	DT	18	det	8135	8138	_	_
49	17	third	third	JJ	18	amod	8139	8144	_	_
49	18	dose	dose	NN	15	dobj	8145	8149	_	_
49	19	of	of	IN	22	case	8150	8152	_	_
49	20	HBV	hbv	NN	22	compound	8153	8156	_	_
49	21	(	(	CD	22	nummod	8157	8158	_	_
49	22	Losonsky	Losonsky	NNP	18	nmod	8158	8166	B-persongroup-7202	_
49	23	,	,	,	22	punct	8166	8167	I-persongroup-7202	_
49	24	unpublished	unpublished	JJ	26	amod	8168	8179	_	_
49	25	data	datum	NNS	26	compound	8180	8184	_	_
49	26	)	)	NN	22	appos	8184	8185	_	_
49	27	.	.	.	10	punct	8185	8186	_	_

50	1	A	a	DT	2	det	8187	8188	_	_
50	2	study	study	NN	12	nsubj	8189	8194	_	_
50	3	of	of	IN	4	case	8195	8197	_	_
50	4	HBV	hbv	NN	2	nmod	8198	8201	_	_
50	5	given	give	VBN	8	case	8202	8207	_	_
50	6	to	to	TO	8	case	8208	8210	_	_
50	7	premature	premature	JJ	8	amod	8211	8220	B-persongroup-7203	_
50	8	infants	infant	NNS	4	acl	8221	8228	I-persongroup-7203	_
50	9	,	,	,	12	punct	8228	8229	I-persongroup-7203	_
50	10	however	however	RB	12	advmod	8230	8237	_	_
50	11	,	,	,	12	punct	8237	8238	_	_
50	12	found	find	VBD	0	ROOT	8239	8244	_	_
50	13	that	that	IN	40	mark	8245	8249	_	_
50	14	only	only	RB	16	advmod	8250	8254	_	_
50	15	54	54	CD	16	nummod	8255	8257	B-persongroup-7204	_
50	16	percent	percent	NN	40	nsubj	8258	8265	I-persongroup-7204	_
50	17	of	of	IN	18	case	8266	8268	I-persongroup-7204	_
50	18	infants	infant	NNS	16	nmod	8269	8276	I-persongroup-7204	_
50	19	with	with	IN	21	case	8277	8281	I-persongroup-7204	_
50	20	birth	birth	NN	21	compound	8282	8287	I-persongroup-7204	_
50	21	weights	weight	NNS	18	nmod	8288	8295	I-persongroup-7204	_
50	22	of	of	IN	26	case	8296	8298	I-persongroup-7204	_
50	23	less	less	JJR	25	advmod	8299	8303	I-persongroup-7204	_
50	24	than	than	IN	23	mwe	8304	8308	I-persongroup-7204	_
50	25	1,000	1,000	CD	26	nummod	8309	8314	I-persongroup-7204	_
50	26	grams	gram	NNS	21	nmod	8315	8320	I-persongroup-7204	_
50	27	and	and	CC	21	cc	8321	8324	_	_
50	28	70	70	CD	29	nummod	8325	8327	B-persongroup-7205	_
50	29	percent	percent	NN	21	conj	8328	8335	I-persongroup-7205	_
50	30	of	of	IN	31	case	8336	8338	I-persongroup-7205	_
50	31	infants	infant	NNS	29	nmod	8339	8346	I-persongroup-7205	_
50	32	with	with	IN	34	case	8347	8351	I-persongroup-7205	_
50	33	birth	birth	NN	34	compound	8352	8357	I-persongroup-7205	_
50	34	weights	weight	NNS	31	nmod	8358	8365	I-persongroup-7205	_
50	35	of	of	IN	39	case	8366	8368	I-persongroup-7205	_
50	36	1,000	1,000	CD	38	compound	8369	8374	I-persongroup-7205	_
50	37	to	to	TO	38	dep	8375	8377	I-persongroup-7205	_
50	38	1,500	1,500	CD	39	nummod	8378	8383	I-persongroup-7205	_
50	39	grams	gram	NNS	34	nmod	8384	8389	I-persongroup-7205	_
50	40	attained	attain	VBD	12	ccomp	8390	8398	_	_
50	41	protective	protective	JJ	43	amod	8399	8409	_	_
50	42	immune	immune	JJ	43	amod	8410	8416	_	_
50	43	responses	response	NNS	40	dobj	8417	8426	_	_
50	44	after	after	IN	45	mark	8427	8432	_	_
50	45	receiving	receive	VBG	40	advcl	8433	8442	_	_
50	46	the	the	DT	48	det	8443	8446	_	_
50	47	third	third	JJ	48	amod	8447	8452	_	_
50	48	dose	dose	NN	45	dobj	8453	8457	_	_
50	49	of	of	IN	51	case	8458	8460	_	_
50	50	the	the	DT	51	det	8461	8464	_	_
50	51	vaccine	vaccine	NN	48	nmod	8465	8472	_	_
50	52	.	.	.	12	punct	8472	8473	_	_

51	1	Thirteen	thirteen	CD	20	nsubjpass	8474	8482	B-persongroup-7206	_
51	2	of	of	IN	5	case	8483	8485	I-persongroup-7206	_
51	3	the	the	DT	5	det	8486	8489	I-persongroup-7206	_
51	4	premature	premature	JJ	5	amod	8490	8499	I-persongroup-7206	_
51	5	infants	infant	NNS	1	nmod	8500	8507	I-persongroup-7206	_
51	6	with	with	IN	12	case	8508	8512	I-persongroup-7206	_
51	7	little	little	JJ	12	amod	8513	8519	I-persongroup-7206	_
51	8	or	or	CC	7	cc	8520	8522	I-persongroup-7206	_
51	9	no	no	DT	7	conj	8523	8525	I-persongroup-7206	_
51	10	detectable	detectable	JJ	12	amod	8526	8536	I-persongroup-7206	_
51	11	antibody	antibody	NN	12	compound	8537	8545	I-persongroup-7206	_
51	12	responses	response	NNS	5	nmod	8546	8555	I-persongroup-7206	_
51	13	to	to	TO	16	case	8556	8558	I-persongroup-7206	_
51	14	the	the	DT	16	det	8559	8562	I-persongroup-7206	_
51	15	three	three	CD	16	nummod	8563	8568	I-persongroup-7206	_
51	16	doses	dose	NNS	12	nmod	8569	8574	I-persongroup-7206	_
51	17	of	of	IN	18	case	8575	8577	I-persongroup-7206	_
51	18	HBV	hbv	NN	16	nmod	8578	8581	I-persongroup-7206	_
51	19	were	be	VBD	20	auxpass	8582	8586	_	_
51	20	given	give	VBN	0	ROOT	8587	8592	_	_
51	21	a	a	DT	23	det	8593	8594	_	_
51	22	fourth	fourth	JJ	23	amod	8595	8601	_	_
51	23	dose	dose	NN	20	dobj	8602	8606	_	_
51	24	of	of	IN	26	case	8607	8609	_	_
51	25	the	the	DT	26	det	8610	8613	_	_
51	26	vaccine	vaccine	NN	23	nmod	8614	8621	_	_
51	27	at	at	IN	31	case	8622	8624	_	_
51	28	9	9	CD	30	compound	8625	8626	_	_
51	29	to	to	TO	30	dep	8627	8629	_	_
51	30	12	12	CD	31	nummod	8630	8632	_	_
51	31	months	month	NNS	20	nmod	8633	8639	_	_
51	32	of	of	IN	33	case	8640	8642	_	_
51	33	age	age	NN	31	nmod	8643	8646	_	_
51	34	.	.	.	20	punct	8646	8647	_	_

52	1	Only	only	RB	3	advmod	8648	8652	_	_
52	2	46	46	CD	3	nummod	8653	8655	B-persongroup-7207	_
52	3	percent	percent	NN	8	nsubj	8656	8663	I-persongroup-7207	_
52	4	of	of	IN	5	case	8664	8666	I-persongroup-7207	_
52	5	these	these	DT	3	nmod	8667	8672	I-persongroup-7207	_
52	6	revaccinated	revaccinate	VBN	5	acl	8673	8685	I-persongroup-7207	_
52	7	infants	infant	NNS	6	dobj	8686	8693	I-persongroup-7207	_
52	8	achieved	achieve	VBD	0	ROOT	8694	8702	_	_
52	9	protective	protective	JJ	11	amod	8703	8713	_	_
52	10	antibody	antibody	NN	11	compound	8714	8722	_	_
52	11	levels	level	NNS	12	nsubj	8723	8729	_	_
52	12	(	(	VBP	8	ccomp	8730	8731	_	_
52	13	Losonsky	Losonsky	NNP	12	dobj	8731	8739	B-persongroup-7208	_
52	14	,	,	,	13	punct	8739	8740	I-persongroup-7208	_
52	15	unpublished	unpublished	JJ	17	amod	8741	8752	_	_
52	16	data	datum	NNS	17	compound	8753	8757	_	_
52	17	)	)	NN	13	appos	8757	8758	_	_
52	18	.	.	.	8	punct	8758	8759	_	_

53	1	These	these	DT	2	det	8760	8765	_	_
53	2	data	datum	NNS	3	nsubj	8766	8770	_	_
53	3	suggest	suggest	VBP	0	ROOT	8771	8778	_	_
53	4	,	,	,	6	punct	8778	8779	_	_
53	5	Losonsky	Losonsky	NNP	6	nsubj	8780	8788	B-persongroup-7209	_
53	6	noted	note	VBD	3	parataxis	8789	8794	_	_
53	7	,	,	,	6	punct	8794	8795	_	_
53	8	the	the	DT	9	det	8796	8799	_	_
53	9	possibility	possibility	NN	12	dep	8800	8811	_	_
53	10	that	that	IN	12	mark	8812	8816	_	_
53	11	tolerance	tolerance	NN	12	nsubj	8817	8826	_	_
53	12	develops	develop	VBZ	3	ccomp	8827	8835	_	_
53	13	in	in	IN	16	case	8836	8838	_	_
53	14	some	some	DT	16	det	8839	8843	B-persongroup-7210	_
53	15	premature	premature	JJ	16	amod	8844	8853	I-persongroup-7210	_
53	16	infants	infant	NNS	12	nmod	8854	8861	I-persongroup-7210	_
53	17	.	.	.	3	punct	8861	8862	I-persongroup-7210	_

54	1	Researchers	researcher	NNS	3	nsubj	8863	8874	B-persongroup-7211	_
54	2	are	be	VBP	3	aux	8875	8878	_	_
54	3	following	follow	VBG	0	ROOT	8879	8888	_	_
54	4	those	those	DT	5	det	8889	8894	B-persongroup-7212	_
54	5	infants	infant	NNS	3	dobj	8895	8902	I-persongroup-7212	_
54	6	who	who	WP	9	nsubj	8903	8906	I-persongroup-7212	_
54	7	did	do	VBD	9	aux	8907	8910	I-persongroup-7212	_
54	8	not	not	RB	9	neg	8911	8914	I-persongroup-7212	_
54	9	respond	respond	VB	5	acl:relcl	8915	8922	I-persongroup-7212	_
54	10	to	to	TO	14	case	8923	8925	I-persongroup-7212	_
54	11	the	the	DT	14	det	8926	8929	I-persongroup-7212	_
54	12	fourth	fourth	JJ	14	amod	8930	8936	I-persongroup-7212	_
54	13	HBV	hbv	NN	14	compound	8937	8940	I-persongroup-7212	_
54	14	dose	dose	NN	9	nmod	8941	8945	I-persongroup-7212	_
54	15	to	to	TO	16	mark	8946	8948	_	_
54	16	see	see	VB	9	xcomp	8949	8952	_	_
54	17	if	if	IN	23	mark	8953	8955	_	_
54	18	their	they	PRP$	19	nmod:poss	8956	8961	_	_
54	19	lack	lack	NN	23	nsubj	8962	8966	_	_
54	20	of	of	IN	21	case	8967	8969	_	_
54	21	response	response	NN	19	nmod	8970	8978	_	_
54	22	is	be	VBZ	23	cop	8979	8981	_	_
54	23	permanent	permanent	JJ	16	advcl	8982	8991	_	_
54	24	.	.	.	3	punct	8991	8992	_	_

55	1	Other	other	JJ	2	amod	8993	8998	_	_
55	2	studies	study	NNS	3	nsubj	8999	9006	_	_
55	3	suggest	suggest	VBP	0	ROOT	9007	9014	_	_
55	4	that	that	IN	20	mark	9015	9019	_	_
55	5	the	the	DT	7	det	9020	9023	_	_
55	6	immune	immune	JJ	7	amod	9024	9030	_	_
55	7	systems	system	NNS	20	nsubj	9031	9038	_	_
55	8	of	of	IN	10	case	9039	9041	_	_
55	9	premature	premature	JJ	10	amod	9042	9051	B-persongroup-7213	_
55	10	infants	infant	NNS	7	nmod	9052	9059	I-persongroup-7213	_
55	11	given	give	VBN	10	acl	9060	9065	_	_
55	12	DPT	DPT	NNP	16	compound	9066	9069	_	_
55	13	and	and	CC	12	cc	9070	9073	_	_
55	14	oral	oral	JJ	12	conj	9074	9078	_	_
55	15	polo	polo	NN	16	compound	9079	9083	_	_
55	16	vaccine	vaccine	NN	11	dobj	9084	9091	_	_
55	17	at	at	IN	19	case	9092	9094	_	_
55	18	standard	standard	JJ	19	amod	9095	9103	_	_
55	19	times	time	NNS	11	nmod	9104	9109	_	_
55	20	respond	respond	VBP	3	ccomp	9110	9117	_	_
55	21	as	as	RB	20	advmod	9118	9120	_	_
55	22	well	well	RB	21	mwe	9121	9125	_	_
55	23	as	as	IN	28	mark	9126	9128	_	_
55	24	those	those	DT	28	nsubj	9129	9134	_	_
55	25	of	of	IN	27	case	9135	9137	_	_
55	26	full-term	full-term	JJ	27	amod	9138	9147	B-persongroup-7214	_
55	27	infants	infant	NNS	24	nmod	9148	9155	I-persongroup-7214	_
55	28	(	(	VBP	21	advcl	9156	9157	_	_
55	29	Koblin	Koblin	NNP	31	nsubj	9157	9163	B-persongroup-7215	_
55	30	et	et	FW	31	compound	9164	9166	_	_
55	31	al.	al.	FW	28	xcomp	9167	9170	_	_
55	32	,	,	,	31	punct	9170	9171	_	_
55	33	1988	1988	CD	31	amod	9172	9176	_	_
55	34	;	;	:	31	punct	9176	9177	_	_
55	35	Conway	Conway	NNP	31	dep	9178	9184	B-persongroup-7216	_
55	36	et	et	FW	37	compound	9185	9187	_	_
55	37	al.	al.	FW	35	dep	9188	9191	_	_
55	38	,	,	,	37	punct	9191	9192	_	_
55	39	1993	1993	CD	37	amod	9193	9197	_	_
55	40	;	;	:	31	punct	9197	9198	_	_
55	41	D'Angio	D'Angio	NNP	31	dep	9199	9206	B-persongroup-7217	_
55	42	et	et	FW	43	compound	9207	9209	_	_
55	43	al.	al.	FW	41	dep	9210	9213	_	_
55	44	,	,	,	31	punct	9213	9214	_	_
55	45	1995	1995	CD	46	nummod	9215	9219	_	_
55	46	)	)	NN	31	appos	9219	9220	_	_
55	47	.	.	.	3	punct	9220	9221	_	_

56	1	However	however	RB	10	advmod	9222	9229	_	_
56	2	,	,	,	10	punct	9229	9230	_	_
56	3	a	a	DT	6	det	9231	9232	_	_
56	4	decreased	decrease	VBN	6	amod	9233	9242	_	_
56	5	immune	immune	JJ	6	amod	9243	9249	_	_
56	6	response	response	NN	10	nsubj	9250	9258	_	_
56	7	to	to	TO	9	case	9259	9261	_	_
56	8	some	some	DT	9	det	9262	9266	_	_
56	9	enhanced-potency	enhanced-potency	NN	6	nmod	9267	9283	_	_
56	10	inactivated	inactivate	VBD	0	ROOT	9284	9295	_	_
56	11	polio-oral	polio-oral	JJ	14	amod	9296	9306	_	_
56	12	polio	polio	NNP	14	compound	9307	9312	_	_
56	13	vaccine	vaccine	NN	14	compound	9313	9320	_	_
56	14	combinations	combination	NNS	25	nsubjpass	9321	9333	_	_
56	15	and	and	CC	14	cc	9334	9337	_	_
56	16	to	to	TO	20	case	9338	9340	_	_
56	17	certain	certain	JJ	20	amod	9341	9348	_	_
56	18	Haemophilus	haemophilus	JJ	20	amod	9349	9360	_	_
56	19	influenzae	influenzae	NN	20	compound	9361	9371	_	_
56	20	type	type	NN	21	nmod	9372	9376	_	_
56	21	b	b	NN	23	amod	9377	9378	_	_
56	22	conjugate	conjugate	NN	23	compound	9379	9388	_	_
56	23	vaccines	vaccine	NNS	14	conj	9389	9397	_	_
56	24	was	be	VBD	25	auxpass	9398	9401	_	_
56	25	seen	see	VBN	10	ccomp	9402	9406	_	_
56	26	in	in	IN	28	case	9407	9409	_	_
56	27	premature	premature	JJ	28	amod	9410	9419	B-persongroup-7218	_
56	28	infants	infant	NNS	25	nmod	9420	9427	I-persongroup-7218	_
56	29	.	.	.	10	punct	9427	9428	I-persongroup-7218	_

57	1	The	the	DT	2	det	9429	9432	_	_
57	2	response	response	NN	3	nsubj	9433	9441	_	_
57	3	depended	depend	VBD	0	ROOT	9442	9450	_	_
57	4	on	on	IN	6	case	9451	9453	_	_
57	5	gestational	gestational	JJ	6	amod	9454	9465	_	_
57	6	age	age	NN	3	nmod	9466	9469	_	_
57	7	and	and	CC	6	cc	9470	9473	_	_
57	8	weight	weight	NN	6	conj	9474	9480	_	_
57	9	at	at	IN	11	case	9481	9483	_	_
57	10	the	the	DT	11	det	9484	9487	_	_
57	11	time	time	NN	3	nmod	9488	9492	_	_
57	12	of	of	IN	16	case	9493	9495	_	_
57	13	the	the	DT	16	det	9496	9499	_	_
57	14	first	first	JJ	16	amod	9500	9505	_	_
57	15	immunization	immunization	NN	16	compound	9506	9518	_	_
57	16	(	(	NN	11	nmod	9519	9520	_	_
57	17	Munoz	Munoz	NNP	16	appos	9520	9525	B-persongroup-7219	_
57	18	et	et	FW	19	compound	9526	9528	_	_
57	19	al.	al.	FW	16	dep	9529	9532	_	_
57	20	,	,	,	19	punct	9532	9533	_	_
57	21	1995	1995	CD	19	amod	9534	9538	_	_
57	22	;	;	:	19	punct	9538	9539	_	_
57	23	D'Angio	D'Angio	NNP	19	dep	9540	9547	B-persongroup-7220	_
57	24	et	et	FW	25	compound	9548	9550	_	_
57	25	al.	al.	FW	23	dep	9551	9554	_	_
57	26	,	,	,	16	punct	9554	9555	_	_
57	27	1995	1995	CD	28	nummod	9556	9560	_	_
57	28	)	)	NN	16	appos	9560	9561	_	_
57	29	.	.	.	3	punct	9561	9562	_	_

58	1	According	accord	VBG	3	case	9563	9572	_	_
58	2	to	to	TO	1	mwe	9573	9575	_	_
58	3	Losonsky	Losonsky	NNP	7	nmod	9576	9584	B-persongroup-7221	_
58	4	,	,	,	7	punct	9584	9585	I-persongroup-7221	_
58	5	these	these	DT	6	det	9586	9591	_	_
58	6	findings	finding	NNS	7	nsubj	9592	9600	_	_
58	7	suggest	suggest	VBP	0	ROOT	9601	9608	_	_
58	8	that	that	IN	20	mark	9609	9613	_	_
58	9	vaccine	vaccine	NN	10	compound	9614	9621	_	_
58	10	schedules	schedule	NNS	20	nsubj	9622	9631	_	_
58	11	,	,	,	10	punct	9631	9632	_	_
58	12	dosages	dosage	NNS	10	conj	9633	9640	_	_
58	13	,	,	,	10	punct	9640	9641	_	_
58	14	and	and	CC	10	cc	9642	9645	_	_
58	15	combinations	combination	NNS	10	conj	9646	9658	_	_
58	16	for	for	IN	18	case	9659	9662	_	_
58	17	preterm	preterm	JJ	18	amod	9663	9670	B-persongroup-7222	_
58	18	infants	infant	NNS	15	nmod	9671	9678	I-persongroup-7222	_
58	19	may	may	MD	20	aux	9679	9682	_	_
58	20	have	have	VB	7	ccomp	9683	9687	_	_
58	21	to	to	TO	22	mark	9688	9690	_	_
58	22	differ	differ	VB	20	xcomp	9691	9697	_	_
58	23	from	from	IN	24	case	9698	9702	_	_
58	24	those	those	DT	22	nmod	9703	9708	_	_
58	25	for	for	IN	27	case	9709	9712	_	_
58	26	full-term	full-term	JJ	27	amod	9713	9722	B-persongroup-7223	_
58	27	infants	infant	NNS	24	nmod	9723	9730	I-persongroup-7223	_
58	28	.	.	.	7	punct	9730	9731	I-persongroup-7223	_

59	1	She	she	PRP	2	nsubj	9732	9735	B-persongroup-7224	_
59	2	added	add	VBD	0	ROOT	9736	9741	_	_
59	3	that	that	IN	15	mark	9742	9746	_	_
59	4	the	the	DT	6	det	9747	9750	_	_
59	5	best	best	JJS	6	amod	9751	9755	_	_
59	6	schedule	schedule	NN	15	nsubjpass	9756	9764	_	_
59	7	and	and	CC	6	cc	9765	9768	_	_
59	8	dosage	dosage	NN	6	conj	9769	9775	_	_
59	9	for	for	IN	11	case	9776	9779	_	_
59	10	each	each	DT	11	det	9780	9784	_	_
59	11	vaccine	vaccine	NN	8	nmod	9785	9792	_	_
59	12	can	can	MD	15	aux	9793	9796	_	_
59	13	not	not	RB	15	neg	9796	9799	_	_
59	14	be	be	VB	15	auxpass	9800	9802	_	_
59	15	predicted	predict	VBN	2	ccomp	9803	9812	_	_
59	16	on	on	IN	18	case	9813	9815	_	_
59	17	theoretical	theoretical	JJ	18	amod	9816	9827	_	_
59	18	grounds	grounds	NNS	15	nmod	9828	9835	_	_
59	19	but	but	CC	2	cc	9836	9839	_	_
59	20	can	can	MD	23	aux	9840	9843	_	_
59	21	only	only	RB	23	advmod	9844	9848	_	_
59	22	be	be	VB	23	auxpass	9849	9851	_	_
59	23	determined	determine	VBN	2	conj	9852	9862	_	_
59	24	by	by	IN	26	case	9863	9865	_	_
59	25	further	further	JJ	26	amod	9866	9873	_	_
59	26	study	study	NN	23	nmod	9874	9879	_	_
59	27	.	.	.	2	punct	9879	9880	_	_

60	1	Care	Care	NNP	4	nsubjpass	9881	9885	_	_
60	2	must	must	MD	4	aux	9886	9890	_	_
60	3	be	be	VB	4	auxpass	9891	9893	_	_
60	4	taken	take	VBN	7	ccomp	9894	9899	_	_
60	5	,	,	,	7	punct	9899	9900	_	_
60	6	she	she	PRP	7	nsubj	9901	9904	B-persongroup-7225	_
60	7	said	say	VBD	0	ROOT	9905	9909	_	_
60	8	,	,	,	7	punct	9909	9910	_	_
60	9	not	not	RB	11	neg	9911	9914	_	_
60	10	to	to	TO	11	mark	9915	9917	_	_
60	11	leave	leave	VB	7	xcomp	9918	9923	_	_
60	12	premature	premature	JJ	13	amod	9924	9933	B-persongroup-7226	_
60	13	infants	infant	NNS	11	dobj	9934	9941	I-persongroup-7226	_
60	14	vaccinated	vaccinate	VBN	13	dep	9942	9952	_	_
60	15	but	but	CC	14	cc	9953	9956	_	_
60	16	unprotected	unprotect	VBN	14	conj	9957	9968	_	_
60	17	from	from	IN	18	case	9969	9973	_	_
60	18	disease	disease	NN	16	nmod	9974	9981	_	_
60	19	.	.	.	7	punct	9981	9982	_	_

61	1	A	a	DT	2	det	9983	9984	B-persongroup-7227	_
61	2	representative	representative	NN	12	nsubj	9985	9999	I-persongroup-7227	_
61	3	of	of	IN	6	case	10000	10002	I-persongroup-7227	_
61	4	the	the	DT	6	det	10003	10006	I-persongroup-7227	_
61	5	National	National	NNP	6	compound	10007	10015	I-persongroup-7227	_
61	6	Institute	Institute	NNP	2	nmod	10016	10025	I-persongroup-7227	_
61	7	of	of	IN	11	case	10026	10028	I-persongroup-7227	_
61	8	Allergy	Allergy	NNP	11	compound	10029	10036	I-persongroup-7227	_
61	9	and	and	CC	8	cc	10037	10040	I-persongroup-7227	_
61	10	Infectious	infectious	JJ	8	conj	10041	10051	I-persongroup-7227	_
61	11	Diseases	disease	NNS	6	nmod	10052	10060	I-persongroup-7227	_
61	12	(	(	VBP	0	ROOT	10061	10062	I-persongroup-7227	_
61	13	NIAID	NIAID	NNP	15	nsubj	10062	10067	I-persongroup-7227	_
61	14	)	)	CD	13	nummod	10067	10068	I-persongroup-7227	_
61	15	pointed	point	VBD	12	ccomp	10069	10076	_	_
61	16	out	out	RP	15	compound:prt	10077	10080	_	_
61	17	,	,	,	15	punct	10080	10081	_	_
61	18	however	however	RB	15	advmod	10082	10089	_	_
61	19	,	,	,	15	punct	10089	10090	_	_
61	20	that	that	IN	34	mark	10091	10095	_	_
61	21	the	the	DT	22	det	10096	10099	_	_
61	22	risk	risk	NN	34	nsubjpass	10100	10104	_	_
61	23	of	of	IN	24	mark	10105	10107	_	_
61	24	inducing	induce	VBG	22	acl	10108	10116	_	_
61	25	tolerance	tolerance	NN	24	dobj	10117	10126	_	_
61	26	to	to	TO	27	case	10127	10129	_	_
61	27	vaccination	vaccination	NN	24	nmod	10130	10141	_	_
61	28	for	for	IN	31	case	10142	10145	_	_
61	29	a	a	DT	31	det	10146	10147	_	_
61	30	specific	specific	JJ	31	amod	10148	10156	_	_
61	31	disease	disease	NN	27	nmod	10157	10164	_	_
61	32	must	must	MD	34	aux	10165	10169	_	_
61	33	be	be	VB	34	auxpass	10170	10172	_	_
61	34	balanced	balance	VBN	15	ccomp	10173	10181	_	_
61	35	with	with	IN	37	case	10182	10186	_	_
61	36	the	the	DT	37	det	10187	10190	_	_
61	37	risk	risk	NN	34	nmod	10191	10195	_	_
61	38	of	of	IN	40	case	10196	10198	_	_
61	39	the	the	DT	40	det	10199	10202	B-persongroup-7228	_
61	40	infant	infant	NN	37	nmod	10203	10209	I-persongroup-7228	_
61	41	dying	die	VBG	34	xcomp	10210	10215	_	_
61	42	or	or	CC	41	cc	10216	10218	_	_
61	43	suffering	suffer	VBG	41	conj	10219	10228	_	_
61	44	long-term	long-term	JJ	45	amod	10229	10238	_	_
61	45	consequences	consequence	NNS	41	dobj	10239	10251	_	_
61	46	from	from	IN	48	case	10252	10256	_	_
61	47	natural	natural	JJ	48	amod	10257	10264	_	_
61	48	infection	infection	NN	41	nmod	10265	10274	_	_
61	49	.	.	.	12	punct	10274	10275	_	_

62	1	Premature	premature	JJ	2	amod	10276	10285	B-persongroup-7229	_
62	2	infants	infant	NNS	9	nsubj	10286	10293	I-persongroup-7229	_
62	3	,	,	,	2	punct	10293	10294	I-persongroup-7229	_
62	4	for	for	IN	5	case	10295	10298	_	_
62	5	example	example	NN	2	nmod	10299	10306	_	_
62	6	,	,	,	2	punct	10306	10307	_	_
62	7	are	be	VBP	9	cop	10308	10311	_	_
62	8	more	more	RBR	9	advmod	10312	10316	_	_
62	9	likely	likely	JJ	0	ROOT	10317	10323	_	_
62	10	to	to	TO	11	mark	10324	10326	_	_
62	11	have	have	VB	9	xcomp	10327	10331	_	_
62	12	respiratory	respiratory	JJ	13	amod	10332	10343	_	_
62	13	abnormalities	abnormality	NNS	11	dobj	10344	10357	_	_
62	14	that	that	WDT	16	nsubj	10358	10362	_	_
62	15	may	may	MD	16	aux	10363	10366	_	_
62	16	put	put	VB	13	acl:relcl	10367	10370	_	_
62	17	them	they	PRP	16	dobj	10371	10375	B-persongroup-7230	_
62	18	at	at	IN	20	case	10376	10378	_	_
62	19	greater	greater	JJR	20	amod	10379	10386	_	_
62	20	risk	risk	NN	16	nmod	10387	10391	_	_
62	21	for	for	IN	22	case	10392	10395	_	_
62	22	complications	complication	NNS	20	nmod	10396	10409	_	_
62	23	from	from	IN	31	case	10410	10414	_	_
62	24	the	the	DT	31	det	10415	10418	_	_
62	25	respiratory	respiratory	JJ	31	amod	10419	10430	_	_
62	26	disease	disease	NN	31	compound	10431	10438	_	_
62	27	pertussis	pertussis	NN	31	compound	10439	10448	_	_
62	28	(	(	NN	31	compound	10449	10450	_	_
62	29	whooping	whooping	JJ	31	amod	10450	10458	_	_
62	30	cough	cough	NN	31	compound	10459	10464	_	_
62	31	)	)	NN	22	nmod	10464	10465	_	_
62	32	.	.	.	9	punct	10465	10466	_	_

63	1	On	on	IN	2	case	10467	10469	_	_
63	2	November	November	NNP	15	nmod	10470	10478	_	_
63	3	6	6	CD	2	nummod	10479	10480	_	_
63	4	,	,	,	2	punct	10480	10481	_	_
63	5	1995	1995	CD	2	nummod	10482	10486	_	_
63	6	,	,	,	15	punct	10486	10487	_	_
63	7	the	the	DT	8	det	10488	10491	_	_
63	8	Institute	Institute	NNP	15	nsubj	10492	10501	_	_
63	9	of	of	IN	14	case	10502	10504	_	_
63	10	Medicine	Medicine	NNP	14	nmod:poss	10505	10513	_	_
63	11	's	's	POS	10	case	10513	10515	_	_
63	12	Vaccine	Vaccine	NNP	14	compound	10516	10523	_	_
63	13	Safety	Safety	NNP	14	compound	10524	10530	_	_
63	14	Forum	Forum	NNP	8	nmod	10531	10536	_	_
63	15	convened	convene	VBD	0	ROOT	10537	10545	_	_
63	16	a	a	DT	17	det	10546	10547	_	_
63	17	workshop	workshop	NN	15	dobj	10548	10556	_	_
63	18	on	on	IN	19	mark	10557	10559	_	_
63	19	detecting	detect	VBG	15	advcl	10560	10569	_	_
63	20	and	and	CC	19	cc	10570	10573	_	_
63	21	responding	respond	VBG	19	conj	10574	10584	_	_
63	22	to	to	TO	24	case	10585	10587	_	_
63	23	adverse	adverse	JJ	24	amod	10588	10595	_	_
63	24	events	event	NNS	21	nmod	10596	10602	_	_
63	25	following	follow	VBG	26	case	10603	10612	_	_
63	26	vaccination	vaccination	NN	24	nmod	10613	10624	_	_
63	27	.	.	.	15	punct	10624	10625	_	_

64	1	Workshop	Workshop	NNP	2	compound	10626	10634	B-persongroup-7231#B-persongroup-7232	_
64	2	speakers	speaker	NNS	5	nsubj	10635	10643	I-persongroup-7231	_
64	3	and	and	CC	2	cc	10644	10647	_	_
64	4	participants	participant	NNS	2	conj	10648	10660	I-persongroup-7232	_
64	5	discussed	discuss	VBD	0	ROOT	10661	10670	_	_
64	6	the	the	DT	7	det	10671	10674	_	_
64	7	difficulties	difficulty	NNS	5	dobj	10675	10687	_	_
64	8	in	in	IN	9	mark	10688	10690	_	_
64	9	detecting	detect	VBG	7	acl	10691	10700	_	_
64	10	adverse	adverse	JJ	11	amod	10701	10708	_	_
64	11	events	event	NNS	19	dep	10709	10715	_	_
64	12	,	,	,	19	punct	10715	10716	_	_
64	13	current	current	JJ	16	amod	10717	10724	_	_
64	14	adverse	adverse	JJ	16	amod	10725	10732	_	_
64	15	events	event	NNS	16	compound	10733	10739	_	_
64	16	detection	detection	NN	19	conj	10740	10749	_	_
64	17	and	and	CC	19	cc	10750	10753	_	_
64	18	response	response	NN	19	conj	10754	10762	_	_
64	19	methods	method	NNS	9	dobj	10763	10770	_	_
64	20	and	and	CC	19	cc	10771	10774	_	_
64	21	procedures	procedure	NNS	19	conj	10775	10785	_	_
64	22	,	,	,	7	punct	10785	10786	_	_
64	23	suggestions	suggestion	NNS	7	conj	10787	10798	_	_
64	24	for	for	IN	25	mark	10799	10802	_	_
64	25	improving	improve	VBG	23	acl	10803	10812	_	_
64	26	the	the	DT	27	det	10813	10816	_	_
64	27	means	means	NNS	25	dobj	10817	10822	_	_
64	28	of	of	IN	29	mark	10823	10825	_	_
64	29	detecting	detect	VBG	27	acl	10826	10835	_	_
64	30	and	and	CC	29	cc	10836	10839	_	_
64	31	responding	respond	VBG	29	conj	10840	10850	_	_
64	32	to	to	TO	34	case	10851	10853	_	_
64	33	adverse	adverse	JJ	34	amod	10854	10861	_	_
64	34	events	event	NNS	31	nmod	10862	10868	_	_
64	35	following	follow	VBG	36	case	10869	10878	_	_
64	36	vaccination	vaccination	NN	34	nmod	10879	10890	_	_
64	37	,	,	,	7	punct	10890	10891	_	_
64	38	and	and	CC	7	cc	10892	10895	_	_
64	39	future	future	JJ	40	amod	10896	10902	_	_
64	40	areas	area	NNS	7	conj	10903	10908	_	_
64	41	of	of	IN	42	case	10909	10911	_	_
64	42	research	research	NN	40	nmod	10912	10920	_	_
64	43	.	.	.	5	punct	10920	10921	_	_

65	1	This	this	DT	2	det	10922	10926	_	_
65	2	document	document	NN	3	nsubj	10927	10935	_	_
65	3	represents	represent	VBZ	0	ROOT	10936	10946	_	_
65	4	a	a	DT	5	det	10947	10948	_	_
65	5	summary	summary	NN	3	dobj	10949	10956	_	_
65	6	of	of	IN	8	case	10957	10959	_	_
65	7	that	that	DT	8	det	10960	10964	_	_
65	8	workshop	workshop	NN	5	nmod	10965	10973	_	_
65	9	.	.	.	3	punct	10973	10974	_	_

66	1	You	you	PRP	3	nsubj	10975	10978	B-persongroup-7233	_
66	2	're	be	VBP	3	aux	10978	10981	I-persongroup-7233	_
66	3	looking	look	VBG	0	ROOT	10982	10989	_	_
66	4	at	at	IN	5	case	10990	10992	_	_
66	5	OpenBook	OpenBook	NNP	3	nmod	10993	11001	_	_
66	6	,	,	,	5	punct	11001	11002	_	_
66	7	NAP.edu	NAP.edu	NNP	11	nmod:poss	11003	11010	B-persongroup-7234	_
66	8	's	's	POS	7	case	11010	11012	I-persongroup-7234	_
66	9	online	online	JJ	11	amod	11013	11019	_	_
66	10	reading	reading	NN	11	compound	11020	11027	_	_
66	11	room	room	NN	5	appos	11028	11032	_	_
66	12	since	since	IN	13	case	11033	11038	_	_
66	13	1999	1999	CD	3	nmod	11039	11043	_	_
66	14	.	.	.	3	punct	11043	11044	_	_

67	1	Based	base	VBN	3	case	11045	11050	_	_
67	2	on	on	IN	3	case	11051	11053	_	_
67	3	feedback	feedback	NN	12	advcl	11054	11062	_	_
67	4	from	from	IN	5	case	11063	11067	_	_
67	5	you	you	PRP	3	nmod	11068	11071	B-persongroup-7235	_
67	6	,	,	,	5	punct	11071	11072	I-persongroup-7235	_
67	7	our	we	PRP$	8	nmod:poss	11073	11076	B-persongroup-7236	_
67	8	users	user	NNS	5	appos	11077	11082	I-persongroup-7236	_
67	9	,	,	,	12	punct	11082	11083	I-persongroup-7236	_
67	10	we	we	PRP	12	nsubj	11084	11086	B-persongroup-7237	_
67	11	've	have	VBP	12	aux	11086	11089	I-persongroup-7237	_
67	12	made	make	VBN	0	ROOT	11090	11094	_	_
67	13	some	some	DT	14	det	11095	11099	_	_
67	14	improvements	improvement	NNS	12	dobj	11100	11112	_	_
67	15	that	that	WDT	16	nsubj	11113	11117	_	_
67	16	make	make	VBP	14	acl:relcl	11118	11122	_	_
67	17	it	it	PRP	22	nsubj	11123	11125	_	_
67	18	easier	easier	JJR	22	dep	11126	11132	_	_
67	19	than	than	IN	20	case	11133	11137	_	_
67	20	ever	ever	RB	18	advcl	11138	11142	_	_
67	21	to	to	TO	22	mark	11143	11145	_	_
67	22	read	read	VB	16	xcomp	11146	11150	_	_
67	23	thousands	thousand	NNS	22	dobj	11151	11160	_	_
67	24	of	of	IN	25	case	11161	11163	_	_
67	25	publications	publication	NNS	23	nmod	11164	11176	_	_
67	26	on	on	IN	28	case	11177	11179	_	_
67	27	our	we	PRP$	28	nmod:poss	11180	11183	_	_
67	28	website	website	NN	25	nmod	11184	11191	_	_
67	29	.	.	.	12	punct	11191	11192	_	_

68	1	Do	do	VB	0	ROOT	11193	11195	_	_
68	2	you	you	PRP	3	nsubj	11196	11199	B-persongroup-7238	_
68	3	want	want	VBP	1	ccomp	11200	11204	_	_
68	4	to	to	TO	5	mark	11205	11207	_	_
68	5	take	take	VB	3	xcomp	11208	11212	_	_
68	6	a	a	DT	8	det	11213	11214	_	_
68	7	quick	quick	JJ	8	amod	11215	11220	_	_
68	8	tour	tour	NN	5	dobj	11221	11225	_	_
68	9	of	of	IN	13	case	11226	11228	_	_
68	10	the	the	DT	11	det	11229	11232	_	_
68	11	OpenBook	OpenBook	NNP	13	nmod:poss	11233	11241	_	_
68	12	's	's	POS	11	case	11241	11243	_	_
68	13	features	feature	NNS	8	nmod	11244	11252	_	_
68	14	?	?	.	1	punct	11252	11253	_	_

69	1	Show	show	NN	0	ROOT	11254	11258	_	_
69	2	this	this	DT	3	det	11259	11263	_	_
69	3	book	book	NN	5	nmod:poss	11264	11268	_	_
69	4	's	's	POS	3	case	11268	11270	_	_
69	5	table	table	NN	1	dobj	11271	11276	_	_
69	6	of	of	IN	7	case	11277	11279	_	_
69	7	contents	contents	NNS	5	nmod	11280	11288	_	_
69	8	,	,	,	5	punct	11288	11289	_	_
69	9	where	where	WRB	12	advmod	11290	11295	_	_
69	10	you	you	PRP	12	nsubj	11296	11299	B-persongroup-7239	_
69	11	can	can	MD	12	aux	11300	11303	_	_
69	12	jump	jump	VB	5	acl:relcl	11304	11308	_	_
69	13	to	to	TO	15	case	11309	11311	_	_
69	14	any	any	DT	15	det	11312	11315	_	_
69	15	chapter	chapter	NN	12	nmod	11316	11323	_	_
69	16	by	by	IN	17	case	11324	11326	_	_
69	17	name	name	NN	12	nmod	11327	11331	_	_
69	18	.	.	.	1	punct	11331	11332	_	_

70	1	...	...	:	3	punct	11333	11336	_	_
70	2	or	or	CC	3	nsubj	11336	11338	_	_
70	3	use	use	VB	0	ROOT	11339	11342	_	_
70	4	these	these	DT	5	det	11343	11348	_	_
70	5	buttons	button	NNS	3	dobj	11349	11356	_	_
70	6	to	to	TO	7	mark	11357	11359	_	_
70	7	go	go	VB	3	xcomp	11360	11362	_	_
70	8	back	back	RB	7	advmod	11363	11367	_	_
70	9	to	to	TO	12	case	11368	11370	_	_
70	10	the	the	DT	12	det	11371	11374	_	_
70	11	previous	previous	JJ	12	amod	11375	11383	_	_
70	12	chapter	chapter	NN	7	nmod	11384	11391	_	_
70	13	or	or	CC	7	cc	11392	11394	_	_
70	14	skip	skip	VB	7	conj	11395	11399	_	_
70	15	to	to	TO	18	case	11400	11402	_	_
70	16	the	the	DT	18	det	11403	11406	_	_
70	17	next	next	JJ	18	amod	11407	11411	_	_
70	18	one	one	CD	14	nmod	11412	11415	_	_
70	19	.	.	.	3	punct	11415	11416	_	_

71	1	Jump	jump	VB	0	ROOT	11417	11421	_	_
71	2	up	up	RP	1	compound:prt	11422	11424	_	_
71	3	to	to	TO	6	case	11425	11427	_	_
71	4	the	the	DT	6	det	11428	11431	_	_
71	5	previous	previous	JJ	6	amod	11432	11440	_	_
71	6	page	page	NN	1	nmod	11441	11445	_	_
71	7	or	or	CC	6	cc	11446	11448	_	_
71	8	down	down	RB	6	conj	11449	11453	_	_
71	9	to	to	TO	12	case	11454	11456	_	_
71	10	the	the	DT	12	det	11457	11460	_	_
71	11	next	next	JJ	12	amod	11461	11465	_	_
71	12	one	one	CD	6	nmod	11466	11469	_	_
71	13	.	.	.	1	punct	11469	11470	_	_

72	1	Also	also	RB	5	advmod	11471	11475	_	_
72	2	,	,	,	5	punct	11475	11476	_	_
72	3	you	you	PRP	5	nsubj	11477	11480	B-persongroup-7240	_
72	4	can	can	MD	5	aux	11481	11484	_	_
72	5	type	type	NN	0	ROOT	11485	11489	_	_
72	6	in	in	IN	9	case	11490	11492	_	_
72	7	a	a	DT	9	det	11493	11494	_	_
72	8	page	page	NN	9	compound	11495	11499	_	_
72	9	number	number	NN	5	nmod	11500	11506	_	_
72	10	and	and	CC	5	cc	11507	11510	_	_
72	11	press	press	NN	12	nsubj	11511	11516	_	_
72	12	Enter	enter	VBP	5	conj	11517	11522	_	_
72	13	to	to	TO	14	mark	11523	11525	_	_
72	14	go	go	VB	12	xcomp	11526	11528	_	_
72	15	directly	directly	RB	14	advmod	11529	11537	_	_
72	16	to	to	TO	18	case	11538	11540	_	_
72	17	that	that	DT	18	det	11541	11545	_	_
72	18	page	page	NN	14	nmod	11546	11550	_	_
72	19	in	in	IN	21	case	11551	11553	_	_
72	20	the	the	DT	21	det	11554	11557	_	_
72	21	book	book	NN	18	nmod	11558	11562	_	_
72	22	.	.	.	5	punct	11562	11563	_	_

73	1	Switch	switch	VB	0	ROOT	11564	11570	_	_
73	2	between	between	IN	5	case	11571	11578	_	_
73	3	the	the	DT	5	det	11579	11582	_	_
73	4	Original	Original	NNP	5	compound	11583	11591	_	_
73	5	Pages	Pages	NNP	1	nmod	11592	11597	_	_
73	6	,	,	,	5	punct	11597	11598	_	_
73	7	where	where	WRB	10	advmod	11599	11604	_	_
73	8	you	you	PRP	10	nsubj	11605	11608	B-persongroup-7241	_
73	9	can	can	MD	10	aux	11609	11612	_	_
73	10	read	read	VB	5	acl:relcl	11613	11617	_	_
73	11	the	the	DT	12	det	11618	11621	_	_
73	12	report	report	NN	10	dobj	11622	11628	_	_
73	13	as	as	IN	15	mark	11629	11631	_	_
73	14	it	it	PRP	15	nsubj	11632	11634	_	_
73	15	appeared	appear	VBD	10	advcl	11635	11643	_	_
73	16	in	in	IN	17	case	11644	11646	_	_
73	17	print	print	NN	15	nmod	11647	11652	_	_
73	18	,	,	,	5	punct	11652	11653	_	_
73	19	and	and	CC	1	cc	11654	11657	_	_
73	20	Text	text	VB	1	conj	11658	11662	_	_
73	21	Pages	Pages	NNP	20	dobj	11663	11668	_	_
73	22	for	for	IN	25	case	11669	11672	_	_
73	23	the	the	DT	25	det	11673	11676	_	_
73	24	web	web	NN	25	compound	11677	11680	_	_
73	25	version	version	NN	21	nmod	11681	11688	_	_
73	26	,	,	,	25	punct	11688	11689	_	_
73	27	where	where	WRB	30	advmod	11690	11695	_	_
73	28	you	you	PRP	30	nsubj	11696	11699	B-persongroup-7242	_
73	29	can	can	MD	30	aux	11700	11703	_	_
73	30	highlight	highlight	VB	25	acl:relcl	11704	11713	_	_
73	31	and	and	CC	30	cc	11714	11717	_	_
73	32	search	search	VB	30	conj	11718	11724	_	_
73	33	the	the	DT	34	det	11725	11728	_	_
73	34	text	text	NN	30	dobj	11729	11733	_	_
73	35	.	.	.	1	punct	11733	11734	_	_

74	1	To	to	TO	2	mark	11735	11737	_	_
74	2	search	search	VB	0	ROOT	11738	11744	_	_
74	3	the	the	DT	5	det	11745	11748	_	_
74	4	entire	entire	JJ	5	amod	11749	11755	_	_
74	5	text	text	NN	2	dobj	11756	11760	_	_
74	6	of	of	IN	8	case	11761	11763	_	_
74	7	this	this	DT	8	det	11764	11768	_	_
74	8	book	book	NN	5	nmod	11769	11773	_	_
74	9	,	,	,	8	punct	11773	11774	_	_
74	10	type	type	NN	8	appos	11775	11779	_	_
74	11	in	in	IN	14	case	11780	11782	_	_
74	12	your	you	PRP$	14	nmod:poss	11783	11787	_	_
74	13	search	search	NN	14	compound	11788	11794	_	_
74	14	term	term	NN	10	nmod	11795	11799	_	_
74	15	here	here	RB	2	advmod	11800	11804	_	_
74	16	and	and	CC	2	cc	11805	11808	_	_
74	17	press	press	VB	2	conj	11809	11814	_	_
74	18	Enter	enter	VB	17	xcomp	11815	11820	_	_
74	19	.	.	.	2	punct	11820	11821	_	_

75	1	Share	share	NN	3	compound	11822	11827	_	_
75	2	a	a	DT	3	det	11828	11829	_	_
75	3	link	link	NN	0	ROOT	11830	11834	_	_
75	4	to	to	TO	7	case	11835	11837	_	_
75	5	this	this	DT	7	det	11838	11842	_	_
75	6	book	book	NN	7	compound	11843	11847	_	_
75	7	page	page	NN	3	nmod	11848	11852	_	_
75	8	on	on	IN	12	case	11853	11855	_	_
75	9	your	you	PRP$	12	nmod:poss	11856	11860	_	_
75	10	preferred	prefer	VBN	12	amod	11861	11870	_	_
75	11	social	social	JJ	12	amod	11871	11877	_	_
75	12	network	network	NN	7	nmod	11878	11885	_	_
75	13	or	or	CC	7	cc	11886	11888	_	_
75	14	via	via	IN	15	case	11889	11892	_	_
75	15	email	email	NN	7	conj	11893	11898	_	_
75	16	.	.	.	3	punct	11898	11899	_	_

76	1	View	View	NNP	0	ROOT	11900	11904	_	_
76	2	our	we	PRP$	4	nmod:poss	11905	11908	_	_
76	3	suggested	suggest	VBN	4	amod	11909	11918	_	_
76	4	citation	citation	NN	1	nmod	11919	11927	_	_
76	5	for	for	IN	7	case	11928	11931	_	_
76	6	this	this	DT	7	det	11932	11936	_	_
76	7	chapter	chapter	NN	4	nmod	11937	11944	_	_
76	8	.	.	.	1	punct	11944	11945	_	_

77	1	Ready	ready	JJ	0	ROOT	11946	11951	_	_
77	2	to	to	TO	3	mark	11952	11954	_	_
77	3	take	take	VB	1	dep	11955	11959	_	_
77	4	your	you	PRP$	6	nmod:poss	11960	11964	_	_
77	5	reading	reading	NN	6	compound	11965	11972	_	_
77	6	offline	offline	NN	3	dobj	11973	11980	_	_
77	7	?	?	.	1	punct	11980	11981	_	_

78	1	Click	click	VB	0	ROOT	11982	11987	_	_
78	2	here	here	RB	1	advmod	11988	11992	_	_
78	3	to	to	TO	4	mark	11993	11995	_	_
78	4	buy	buy	VB	1	xcomp	11996	11999	_	_
78	5	this	this	DT	6	det	12000	12004	_	_
78	6	book	book	NN	4	dobj	12005	12009	_	_
78	7	in	in	IN	8	case	12010	12012	_	_
78	8	print	print	NN	6	nmod	12013	12018	_	_
78	9	or	or	CC	1	cc	12019	12021	_	_
78	10	download	download	VB	1	conj	12022	12030	_	_
78	11	it	it	PRP	10	dobj	12031	12033	_	_
78	12	as	as	IN	15	case	12034	12036	_	_
78	13	a	a	DT	15	det	12037	12038	_	_
78	14	free	free	JJ	15	amod	12039	12043	_	_
78	15	PDF	pdf	NN	10	nmod	12044	12047	_	_
78	16	,	,	,	10	punct	12047	12048	_	_
78	17	if	if	IN	18	mark	12049	12051	_	_
78	18	available	available	JJ	10	advcl	12052	12061	_	_
78	19	.	.	.	1	punct	12061	12062	_	_

79	1	Do	do	VB	0	ROOT	12063	12065	_	_
79	2	you	you	PRP	3	nsubj	12066	12069	B-persongroup-7243	_
79	3	enjoy	enjoy	VB	1	ccomp	12070	12075	_	_
79	4	reading	read	VBG	3	xcomp	12076	12083	_	_
79	5	reports	report	NNS	4	dobj	12084	12091	_	_
79	6	from	from	IN	8	case	12092	12096	_	_
79	7	the	the	DT	8	det	12097	12100	_	_
79	8	Academies	Academies	NNPS	4	nmod	12101	12110	_	_
79	9	online	online	NN	11	dep	12111	12117	_	_
79	10	for	for	IN	11	case	12118	12121	_	_
79	11	free	free	JJ	4	advcl	12122	12126	_	_
79	12	?	?	.	1	punct	12126	12127	_	_

80	1	Sign	sign	VB	0	ROOT	12128	12132	_	_
80	2	up	up	RP	1	compound:prt	12133	12135	_	_
80	3	for	for	IN	5	case	12136	12139	_	_
80	4	email	email	NN	5	compound	12140	12145	_	_
80	5	notifications	notification	NNS	1	nmod	12146	12159	_	_
80	6	and	and	CC	1	cc	12160	12163	_	_
80	7	we	we	PRP	9	nsubj	12164	12166	_	_
80	8	'll	will	MD	9	aux	12166	12169	_	_
80	9	let	let	VB	1	conj	12170	12173	_	_
80	10	you	you	PRP	11	nsubj	12174	12177	B-persongroup-7244	_
80	11	know	know	VB	9	ccomp	12178	12182	_	_
80	12	about	about	IN	14	case	12183	12188	_	_
80	13	new	new	JJ	14	amod	12189	12192	_	_
80	14	publications	publication	NNS	11	nmod	12193	12205	_	_
80	15	in	in	IN	17	case	12206	12208	_	_
80	16	your	you	PRP$	17	nmod:poss	12209	12213	_	_
80	17	areas	area	NNS	14	nmod	12214	12219	_	_
80	18	of	of	IN	19	case	12220	12222	_	_
80	19	interest	interest	NN	17	nmod	12223	12231	_	_
80	20	when	when	WRB	23	advmod	12232	12236	_	_
80	21	they	they	PRP	23	nsubjpass	12237	12241	_	_
80	22	're	be	VBP	23	auxpass	12241	12244	_	_
80	23	released	release	VBN	11	ccomp	12245	12253	_	_
80	24	.	.	.	1	punct	12253	12254	_	_
